syndrome	score	normalized_score
DRAVET SYNDROME	2.6655187	100.0
CHILDHOOD ABSENCE EPILEPSY	1.52074085	57.05234219516074
SECKEL SYNDROME 10; SCKL10	1.25	46.89518779215468
MYOCLONIC-ASTASTIC EPILEPSY	1.22839834	46.084776670296854
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.1936939999999998	44.78280343709462
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.1521162600000001	43.22296669687593
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	1.0172660199999999	38.163904833982215
TRICARBOXYLIC ACID CYCLE, DEFECT OF	1.0172414	38.16298118636347
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	1.014250339	38.05076809252924
PAROXYSMAL KINESIGENIC DYSKINESIA	1.00980392	37.88395556932315
SENGERS SYNDROME	1.00684932	37.77311035184259
DEAFNESS, AUTOSOMAL DOMINANT 34, WITH OR WITHOUT INFLAMMATION; DFNA34	1.00537634	37.71784981287132
LOWRY-MACLEAN SYNDROME	1.000541419	37.53646219026713
CHIARI MALFORMATION TYPE II	1.0	37.51615023372374
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	1.0	37.51615023372374
PERIPHERAL NEUROPATHY, ATAXIA, FOCAL NECROTIZING ENCEPHALOPATHY, AND	1.0	37.51615023372374
OCULOSKELETODENTAL SYNDROME; OCSKD	1.0	37.51615023372374
SPLENOPORTAL VASCULAR ANOMALIES	1.0	37.51615023372374
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	37.51615023372374
MYOCLONIC EPILEPSY OF LAFORA	0.93444076	35.05661993667499
RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTALRETARDATION	0.933333	35.015061046092086
LAFORA DISEASE	0.7769052999999999	29.14649595217621
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706170999999999	28.910586896276513
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.7480334099999999	28.063333789404666
EARLY MYOCLONIC ENCEPHALOPATHY	0.7178921	26.932547875203426
GITELMAN SYNDROME	0.70638644	26.50089980610528
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.6794116299999999	25.488908781619124
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.6510022200000002	24.423097088007683
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.645995919	24.235279947576434
GLUTARIC ACIDEMIA I; GA1	0.628735789	23.587746317442836
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.611862489	22.95472505970414
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.6103603	22.898368711500694
PAROXYSMAL HEMICRANIA	0.6098039199999999	22.877495475833655
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.6055556	22.71811486447272
ROLANDIC EPILEPSY	0.60042522	22.52564275763663
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.5999174890000001	22.506594645162316
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.5927414099999999	22.237375787309237
HSD10 DISEASE	0.583874419	21.904720420832167
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.5555556	20.842307352786534
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.535437929	20.087569785197907
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5333330000000001	20.00860095260259
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.52601025	19.733879563478585
GLYCOGEN STORAGE DISEASE IC; GSD1C	0.52412562	19.6631755012636
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.5209282599999999	19.543222863152298
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.50980392	19.12588045246128
GLYCINE ENCEPHALOPATHY	0.50925926	19.10544690607498
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.50925926	19.10544690607498
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	19.022273225845314
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.50392157	18.905197326133937
INHALATIONAL ANTHRAX	0.50373134	18.898060628874973
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.5	18.75807511686187
CREST SYNDROME	0.5	18.75807511686187
TRIGEMINAL NEURALGIA	0.5	18.75807511686187
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.5	18.75807511686187
RENAL TUBULAR ACIDOSIS III	0.5	18.75807511686187
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.75807511686187
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.5	18.75807511686187
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.5	18.75807511686187
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.5	18.75807511686187
BARTH SYNDROME; BTHS	0.5	18.75807511686187
CLUSTER HEADACHE, FAMILIAL	0.5	18.75807511686187
179830 RENAL TUBULAR ACIDOSIS, PROXIMAL;;RENAL TUBULAR ACIDOSIS II;;RTA, PROXIMAL TYPE;;RTA, RATE TYPE	0.47878750000000003	17.96226378002901
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.457390739	17.159539679837927
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.45148625	16.938025983460555
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.42074085000000006	15.784576938064628
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.41458575	15.553661281761034
SPINOCEREBELLAR ATAXIA TYPE 10	0.4088913	15.340027440062606
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.38836981000000004	14.570140138202747
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.37769549	14.169680745439905
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.3655911	13.715570631712321
PERIORAL MYOCLONIA WITH ABSENCES	0.36455991	13.676884352752804
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.412686243769365
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.412686243769365
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.35559819	13.340675118880238
CENTRALOPATHIC EPILEPSY	0.3547009	13.307012252437023
ACUTE ADRENAL INSUFFICIENCY	0.35423968899999997	13.289709391271575
GLUTATHIONE SYNTHETASE DEFICIENCY	0.3505744	13.15220185849756
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.350541419	13.150964538346704
INSULINOMA	0.34974801899999997	13.121199224751265
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.34717765	13.024768875191159
HYDROXYKYNURENINURIA	0.3437497	12.896165387997465
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.34371795	12.894974250227545
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.34259226	12.852742695070946
ADDISON DISEASE	0.34054108899999996	12.775790655679886
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.34054108899999996	12.775790655679886
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.769569014841279
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.34018232	12.762331023976683
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.33894578899999994	12.715941141212026
COG4-CDG	0.33725457	12.6524931151299
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.333874419	12.525682862401228
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.333874419	12.525682862401228
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.333874419	12.525682862401228
GLUTATHIONE SYNTHETASE DEFICIENCY	0.333874419	12.525682862401228
OROFACIODIGITAL SYNDROME TYPE 3	0.333333	12.505370905857834
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.333333	12.505370905857834
PSEUDOHYPOALDOSTERONISM, TYPE II	0.333333	12.505370905857834
NEUROMYELITIS OPTICA	0.333333	12.505370905857834
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	12.505370905857834
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	12.505370905857834
CYSTINOSIS, NEPHROPATHIC; CTNS	0.333333	12.505370905857834
EPIDERMAL NEVUS SYNDROME	0.333333	12.505370905857834
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.32922692000000003	12.35132659170615
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.3215277	12.06248149750366
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.316962989	11.891231113854126
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.31666669999999997	11.880115491217525
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.31044459999999996	11.646686252848273
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.3055556	11.463269794355597
HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE	0.30000000000000004	11.254845070117124
INSULIN AUTOIMMUNE SYNDROME	0.27777799999999997	10.421161179623313
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.27370895000000006	10.268506088514782
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.26637682	9.993432797901589
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.26171085	9.81838356639554
PITUITARY APOPLEXY	0.26039801	9.7691308637227
BIOTINIDASE DEFICIENCY	0.25925926	9.726409347644044
LEPTOSPIROSIS	0.25910768	9.720722649591618
SHEEHAN SYNDROME	0.25666667	9.629145351709594
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.25508440000000004	9.569784672679283
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.25220834000000003	9.46188597363808
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.25114939999999997	9.422158621509578
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.250541419	9.399349514974329
ARGININOSUCCINIC ACIDURIA	0.250541419	9.399349514974329
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.250541419	9.399349514974329
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.250541419	9.399349514974329
PITUITARY DEFICIENCY DUE TO RATHKE CLEFT CYSTS	0.25	9.379037558430936
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.25	9.379037558430936
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.25	9.379037558430936
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	9.379037558430936
LACTIC ACIDOSIS, CHRONIC ADULT FORM	0.25	9.379037558430936
HYPEREKPLEXIA 1; HKPX1	0.25	9.379037558430936
PALLISTER-HALL SYNDROME	0.25	9.379037558430936
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.25	9.379037558430936
LENNOX-GASTAUT SYNDROME	0.24200527	9.079106066672878
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.23944559	8.98307672724262
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.237037	8.892715702951175
BENIGN SCHWANNOMA	0.237037	8.892715702951175
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6; MC3DN6	0.2272471	8.525436343778043
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915	8.475991933577506
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.22272730000000002	8.355870847951659
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.22258475900000002	8.350523258381195
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.22112998900000003	8.29594588850568
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.21743390899999998	8.157283195949816
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.21630151	8.1147999449413
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.21429598	8.039560180163058
AICARDI-GOUTIÈRES SYNDROME	0.20983932900000002	7.872363791707785
MALARIA	0.20910768000000002	7.84491513790543
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.20704225	7.76742815572819
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.20684932	7.760190164863598
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.204462989	7.670664212560206
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2; FASPS2	0.20424822	7.662606906490659
POLYARTERITIS NODOSA	0.20373134	7.643215558757851
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.200541419	7.523542003288142
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.200541419	7.523542003288142
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.200541419	7.523542003288142
SUCCINYL-COA:3-OXOACID COA TRANSFERASE DEFICIENCY	0.2	7.50323004674475
SHOX-RELATED SHORT STATURE	0.2	7.50323004674475
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.2	7.50323004674475
MEDULLARY SPONGE KIDNEY	0.2	7.50323004674475
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.2	7.50323004674475
BRAIN-LUNG-THYROID SYNDROME	0.2	7.50323004674475
ALPHA-METHYLACETOACETIC ACIDURIA	0.2	7.50323004674475
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.2	7.50323004674475
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.2	7.50323004674475
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	7.50323004674475
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.19652777999999999	7.372965719580208
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10	0.19444430000000001	7.29480157089125
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11	0.19444430000000001	7.29480157089125
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	0.19444430000000001	7.29480157089125
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	0.19444430000000001	7.29480157089125
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	0.19444430000000001	7.29480157089125
MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2	0.19444430000000001	7.29480157089125
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	0.19444430000000001	7.29480157089125
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.19195567	7.201437753935097
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.18939175000000003	7.105249346027849
JUVENILE MYOCLONIC EPILEPSY	0.18297529999999998	6.864528843860672
UNILATERAL POLYMICROGYRIA	0.18170029999999998	6.816695752312674
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.18159240000000001	6.812647759702456
MYOCLONIC EPILEPSY OF INFANCY	0.18074025999999999	6.780678747442289
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.18074025999999999	6.780678747442289
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.18016861999999995	6.759233015322683
HEREDITARY FRUCTOSE INTOLERANCE	0.177625119	6.663810649687058
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.173875089	6.523123960826087
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.170996299	6.415122842694744
KIKUCHI-FUJIMOTO DISEASE	0.17058857000000002	6.3998264202761
DERMATOLEUKODYSTROPHY	0.166667	6.252704211004036
PRIMARY MYELOFIBROSIS	0.166667	6.252704211004036
CRYPTOSPORIDIOSIS	0.166667	6.252704211004036
PROPROTEIN CONVERTASE 1/3 DEFICIENCY	0.166667	6.252704211004036
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.166667	6.252704211004036
CEREBROOCULONASAL SYNDROME	0.166667	6.252704211004036
DRACUNCULIASIS	0.166667	6.252704211004036
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	6.252704211004036
MUCOLIPIDOSIS TYPE II	0.166667	6.252704211004036
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.16574656999999998	6.218173220844408
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.16406004	6.154901107990726
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.1595057	5.98403980433527
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.1595057	5.98403980433527
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.15486339999999998	5.809878580105253
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15211625999999998	5.7068164631521805
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.1515915	5.6871294881555325
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.148148	5.557942624825705
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.14285699999999998	5.3594446739390715
COMBINED SAPOSIN DEFICIENCY	0.14285699999999998	5.3594446739390715
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.14285699999999998	5.3594446739390715
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.3594446739390715
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.1415488	5.310366046203315
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.13835809999999998	5.190663265652573
PULMONARY ARTERIOVENOUS MALFORMATION	0.136968739	5.138539789647697
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.136968739	5.138539789647697
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4; HHT4	0.13642732000000002	5.118227833104305
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.13624340000000001	5.111327862753318
PROPIONIC ACIDEMIA	0.135778039	5.093869309564401
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.1324787	4.970090811968418
FAMILIAL HYPOALDOSTERONISM	0.1316933	4.9406256275748515
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.13007899999999997	4.880063306252549
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.12901942	4.840311943787902
COLCHICINE POISONING	0.12856995	4.8234495597423495
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.1270754	4.7673797974105385
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.1266234	4.7504224975048945
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.1266234	4.7504224975048945
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.12429182999999999	4.662950967104451
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.12280404	4.60713481394822
PEHO-LIKE SYNDROME; PEHOL	0.12260529999999999	4.599678854250769
COG8-CDG	0.12224065899999999	4.585998927713394
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.12197001900000001	4.57584555681414
GALACTOSEMIA	0.12152769999999999	4.559251450758908
PSEUDOHYPOALDOSTERONISM, TYPE IIE; PHA2E	0.12152769999999999	4.559251450758908
PSEUDOHYPOALDOSTERONISM, TYPE IIC	0.12152769999999999	4.559251450758908
TIGLIC ACIDEMIA	0.1213235	4.551590652881182
PYRUVATE CARBOXYLASE DEFICIENCY	0.12109965900000001	4.543193000296716
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.12037025999999999	4.515828757832387
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	4.432655077602719
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.11796315000000002	4.42552325744329
MELAS	0.11780238000000003	4.419491785970214
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.11665568000000003	4.376472016497203
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.11544029899999998	4.330875600309988
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.11538375899999999	4.328754437175773
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.11369860000000001	4.265533758964063
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.1136364	4.263200254419525
PEHO SYNDROME; PEHO	0.11165241899999999	4.188768925162671
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.11165241899999999	4.188768925162671
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.11165241899999999	4.188768925162671
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.1114943	4.182836909003865
ENTERIC ANENDOCRINOSIS	0.11111099999999999	4.168456968619278
SAY-BARBER-MILLER SYNDROME	0.11111099999999999	4.168456968619278
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	0.11111099999999999	4.168456968619278
RENAL AGENESIS, BILATERAL	0.11111099999999999	4.168456968619278
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.11111099999999999	4.168456968619278
DIARRHEA 4, MALABSORPTIVE, CONGENITAL	0.11111099999999999	4.168456968619278
NEPHROPATHIC INFANTILE CYSTINOSIS	0.11111099999999999	4.168456968619278
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.11111099999999999	4.168456968619278
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.11095811900000001	4.162721462055397
ADULT ACUTE RESPIRATORY DISTRESS SYNDROME	0.1104167	4.1424095055120045
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.10835452900000002	4.065044788468377
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.107583669	4.036125088899208
OCULOCEREBRORENAL SYNDROME OF LOWE	0.10739073900000001	4.028887098034616
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.10666667	4.001722816651034
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.10621331	3.984714494781073
GLYCOGEN STORAGE DISEASE 0, LIVER	0.104373539	3.9156933695494245
BILATERAL POLYMICROGYRIA	0.10411521	3.9060018599756967
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.10373134	3.8916005353854777
AICARDI SYNDROME; AIC	0.1036867	3.8899258144390436
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.1017026	3.8154900207603126
HISTIOCYTOID CARDIOMYOPATHY	0.10131497900000001	3.8009479730905666
MALIGNANT ATROPHIC PAPULOSIS	0.101254439	3.7986767453554164
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.101254439	3.7986767453554164
PFAPA SYNDROME	0.10071302000000001	3.778364788812025
LOWE OCULOCEREBRORENAL SYNDROME	0.100541419	3.771926979915767
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.100541419	3.771926979915767
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.100541419	3.771926979915767
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.1	3.751615023372375
INSULIN-RESISTANCE SYNDROME TYPE B	0.1	3.751615023372375
PARAGANGLIOMAS 1	0.1	3.751615023372375
CARNEY COMPLEX	0.1	3.751615023372375
SAY SYNDROME	0.1	3.751615023372375
ARNOLD-CHIARI MALFORMATION TYPE I	0.1	3.751615023372375
RABSON-MENDENHALL SYNDROME	0.1	3.751615023372375
NON-FUNCTIONING PARAGANGLIOMA	0.1	3.751615023372375
PARAGANGLIOMAS 3	0.1	3.751615023372375
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.1	3.751615023372375
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.1	3.751615023372375
RAVINE SYNDROME	0.1	3.751615023372375
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.1	3.751615023372375
LI-FRAUMENI SYNDROME	0.1	3.751615023372375
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.1	3.751615023372375
X-LINKED ACROGIGANTISM	0.1	3.751615023372375
PARAGANGLIOMAS 4	0.1	3.751615023372375
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09840755000000001	3.6918724299326815
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185	3.681154065810906
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.0978483	3.670891522914471
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.0978483	3.670891522914471
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.0978483	3.670891522914471
HEPATOCELLULAR CARCINOMA	0.09765288000000001	3.663560116835797
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.09764164	3.66313843530717
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.09758363900000001	3.660962461077464
BETA-KETOTHIOLASE DEFICIENCY	0.09487214899999999	3.5592377948802234
INFANTILE LIVER FAILURE SYNDROME 2	0.09446295900000001	3.5438865613660866
SILVER-RUSSELL SYNDROME	0.09415590000000001	3.5323668897914695
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.09382909	3.5201062367335862
CITRULLINEMIA TYPE I	0.09367863900000001	3.5144618944147727
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.09330630000000001	3.5004931685528975
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.09330630000000001	3.5004931685528975
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.09330630000000001	3.5004931685528975
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.09330630000000001	3.5004931685528975
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.09330630000000001	3.5004931685528975
STORMORKEN SYNDROME; STRMK	0.09313722000000002	3.4941499378713803
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.09145080000000001	3.4308819517942233
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.09145051900000001	3.430871409756008
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.09145051900000001	3.430871409756008
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.0909091	3.410559453212615
ARTERIAL TORTUOSITY SYNDROME	0.0909091	3.410559453212615
MACHADO-JOSEPH DISEASE TYPE 1	0.0909091	3.410559453212615
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.0909091	3.410559453212615
MACHADO-JOSEPH DISEASE TYPE 3	0.0909091	3.410559453212615
MACHADO-JOSEPH DISEASE TYPE 2	0.0909091	3.410559453212615
SPINOCEREBELLAR ATAXIA TYPE 3	0.0909091	3.410559453212615
BETA-THALASSEMIA	0.0909091	3.410559453212615
ULNAR-MAMMARY SYNDROME	0.0909091	3.410559453212615
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.090350999	3.389621652251024
CONGENITAL ISOLATED ACTH DEFICIENCY	0.0900384	3.3778941412041124
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.08925105900000001	3.348356137962942
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.088945789	3.336903582781093
CITRULLINEMIA TYPE II	0.08779628900000001	3.2937787680874275
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.08779628900000001	3.2937787680874275
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.08760605900000001	3.2866420708284667
ACUTE BILIRUBIN ENCEPHALOPATHY	0.08760605900000001	3.2866420708284667
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.08760605900000001	3.2866420708284667
PRIMARY HEPATIC NEUROENDOCRINE CARCINOMA	0.08725487000000001	3.2734668115440355
DPM3-CDG	0.08725487000000001	3.2734668115440355
HEPATIC VENO-OCCLUSIVE DISEASE	0.08725487000000001	3.2734668115440355
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.087167039	3.270171730552857
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.08635400000000001	3.2396696372829803
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.08502421900000001	3.189781373509029
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.08502421900000001	3.189781373509029
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.08502421900000001	3.189781373509029
GLYCEROL KINASE DEFICIENCY; GKD	0.084291489	3.1622921647482727
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.084291489	3.1622921647482727
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.08387471900000001	3.146656558815364
RFT1-CDG	0.08387471900000001	3.146656558815364
INHERITED CREUTZFELDT-JAKOB DISEASE	0.08387471900000001	3.146656558815364
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.083856129	3.1459591335825183
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.083616229	3.136959009141448
PATENT DUCTUS VENOSUS	0.08333330000000001	3.1263446022719714
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1	0.08333330000000001	3.1263446022719714
PERIPARTUM CARDIOMYOPATHY	0.08333330000000001	3.1263446022719714
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.08113734	3.043960637004723
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.08113734	3.043960637004723
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.07904281	2.9653819348556816
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.07840243999999999	2.9413577177305115
WOLCOTT-RALLISON SYNDROME	0.077796359	2.9186198918807063
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.07692310000000001	2.885858576043755
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.07692310000000001	2.885858576043755
MAPLE SYRUP URINE DISEASE; MSUD	0.076750339	2.8793772484132263
LYSOSOMAL ACID LIPASE DEFICIENCY	0.07644367	2.867872208137201
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.07515994000000001	2.8197116005976626
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.07461872	2.7994071097681665
GLYCOGEN STORAGE DISEASE IXC	0.07346382	2.756079707863239
METHYLMALONIC ACIDURIA, CBLA TYPE	0.073458119	2.7558658282907564
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.073243019	2.7477961043754826
GLYCOGEN STORAGE DISEASE IXA	0.07308824	2.741989392158457
METHYLMALONIC ACIDURIA, CBLB TYPE	0.0729167	2.735553871747364
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.07289361	2.734687623838467
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.07204304	2.702777511934169
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.07197001900000001	2.7000380451279526
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.07197001900000001	2.7000380451279526
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.07197001900000001	2.7000380451279526
TUBEROUS SCLEROSIS COMPLEX	0.0715302	2.683537729448306
SCHINZEL-GIEDION SYNDROME	0.07142860000000001	2.67972608858456
%609197 GLUCOCORTICOID DEFICIENCY 3; GCCD3;;FAMILIAL GLUCOCORTICOID DEFICIENCY 3; FGD3;;GLUCOCORTICOID DEFICIENCY 2, FORMERLY; GCCD2, FORMERLY	0.07142860000000001	2.67972608858456
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.07142860000000001	2.67972608858456
TEMPLE SYNDROME	0.07142860000000001	2.67972608858456
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.07142860000000001	2.67972608858456
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.07077939999999999	2.655370603852826
HYDROXYKYNURENINURIA	0.07068150000000001	2.6516977727449453
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.07019114000000001	2.6333013533163365
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.069708089	2.6151791394297854
SHORT STATURE DUE TO GHSR DEFICIENCY	0.06916667	2.594867182886393
VON HIPPEL-LINDAU DISEASE	0.06862742	2.574636598872857
XP21 MICRODELETION SYNDROME	0.067208119	2.5213898893299826
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.067208119	2.5213898893299826
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.067208119	2.5213898893299826
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.5010779327865906
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.0666667	2.5010779327865906
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.5010779327865906
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.0666667	2.5010779327865906
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.0666667	2.5010779327865906
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0666667	2.5010779327865906
DIABETES MELLITUS, KETOSIS-PRONE; KPD	0.0666667	2.5010779327865906
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.0666667	2.5010779327865906
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.5010779327865906
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.0666667	2.5010779327865906
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.0666667	2.5010779327865906
DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM	0.0666667	2.5010779327865906
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.0666667	2.5010779327865906
AUTOIMMUNE HYPOPARATHYROIDISM	0.0666667	2.5010779327865906
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.0666667	2.5010779327865906
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.06665754	2.50073428485045
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.06549017	2.4569390565521076
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.06549017	2.4569390565521076
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.06535621900000001	2.4519137307121506
ACQUIRED METHEMOGLOBINEMIA	0.064741259	2.428842798964419
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.06433827	2.4137242030978814
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.06389694900000001	2.3971675381605846
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.06348501	2.381713172749454
ALAGILLE SYNDROME 1; ALGS1	0.06307467	2.366318795662548
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.06274507	2.3539534725455127
INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	0.06274507	2.3539534725455127
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.06259785000000001	2.3484303449081043
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.06240754999999999	2.341291021518626
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.06096382	2.287127829941692
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.059887489	2.246748034444478
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.05979277	2.24319454221049
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.05979277	2.24319454221049
VICI SYNDROME; VICIS	0.059364919	2.2271432198168415
MOYAMOYA DISEASE	0.059364919	2.2271432198168415
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.059140269999999995	2.218715254182985
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.058958079999999996	2.2118801867719027
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 1	0.0588235	2.2068312632734486
SEVERE HEREDITARY THROMBOPHILIA DUE TO CONGENITAL PROTEIN C DEFICIENCY	0.0588235	2.2068312632734486
SEVERE HEREDITARY THROMBOPHILIA DUE TO CONGENITAL PROTEIN S DEFICIENCY	0.0588235	2.2068312632734486
VEIN OF GALEN ANEURYSMAL MALFORMATION	0.0588235	2.2068312632734486
AMINO ACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY,OSTEOPOROSIS, AND ACIDOSIS	0.0588235	2.2068312632734486
3M SYNDROME	0.0588235	2.2068312632734486
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.0588235	2.2068312632734486
CEREBRAL ARTERIOVENOUS MALFORMATION	0.0588235	2.2068312632734486
HEMIHYPERPLASIA-MULTIPLE LIPOMATOSIS SYNDROME	0.0588235	2.2068312632734486
FANCONI RENOTUBULAR SYNDROME 1; FRTS1	0.0588235	2.2068312632734486
WERNER SYNDROME	0.0588235	2.2068312632734486
LYMPHEDEMA-CEREBRAL ARTERIOVENOUS ANOMALY SYNDROME	0.0588235	2.2068312632734486
GAPO SYNDROME	0.0588235	2.2068312632734486
LYMPHEDEMA AND CEREBRAL ARTERIOVENOUS ANOMALY	0.0588235	2.2068312632734486
PSEUDOXANTHOMA ELASTICUM	0.0588235	2.2068312632734486
GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 1; GFND1	0.0588235	2.2068312632734486
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 4	0.0588235	2.2068312632734486
ATYPICAL WERNER SYNDROME	0.0588235	2.2068312632734486
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.057777909999999995	2.167604751750569
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.056584159	2.1228198098929116
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.084232235924663
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	2.084232235924663
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	2.084232235924663
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.055555600000000004	2.084232235924663
WHITE-SUTTON SYNDROME; WHSUS	0.055555600000000004	2.084232235924663
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.055555600000000004	2.084232235924663
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	2.084232235924663
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.055229069	2.0719820498726946
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.054462989	2.0432416775016438
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.053342589	2.0012085827797796
KEARNS-SAYRE SYNDROME; KSS	0.053038169	1.9897879163256293
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.052845239	1.982549925461037
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.05241194	1.9662942150809146
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.9201185495340927
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.050735659999999995	1.9034066427671283
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.050541419000000004	1.8961194682295797
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.050541419000000004	1.8961194682295797
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.050541419000000004	1.8961194682295797
KAPOSI SARCOMA	0.0502023	1.8833970288784692
OSTEOPETROSIS AND RELATED DISORDERS	0.04918584	1.8452633628118986
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.048710929	1.8274465303882506
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.0485313	1.820707541837917
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.046509089999999996	1.7448420076737785
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.046059639000000006	1.7279803364350814
VICI SYNDROME	0.045995919	1.7255898073421885
DILATED CARDIOMYOPATHY WITH ATAXIA	0.045795109	1.7180561892137542
FAMILIAL CERVICAL ARTERY DISSECTION	0.045518220000000005	1.707668379891689
VASCULAR EHLERS-DANLOS SYNDROME	0.045518220000000005	1.707668379891689
HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA	0.0454545	1.7052778507987958
RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL DOMINANT	0.0454545	1.7052778507987958
RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS	0.0454545	1.7052778507987958
ALAGILLE SYNDROME 2	0.0454545	1.7052778507987958
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.045363399000000006	1.7018600919963538
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.04513573	1.6933188275887918
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.6854321824866583
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.042756550000000004	1.604061153275721
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.042756550000000004	1.604061153275721
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.0427032	1.6020596666607516
DISTAL MONOSOMY 12Q	0.041666699999999994	1.5631741769434968
COG2-CDG	0.041666699999999994	1.5631741769434968
FAMILIAL THROMBOCYTOSIS	0.041632059000000006	1.561874579983251
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.041632059000000006	1.561874579983251
HYPOTONIA-CYSTINURIA SYNDROME	0.04152505	1.5578600142628902
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.04152505	1.5578600142628902
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.0414764	1.5560348535540194
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.041459989	1.555419176012534
NEONATAL ADRENOLEUKODYSTROPHY	0.041366299	1.5519042878971363
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.04082488	1.5315923313537438
BLAU SYNDROME	0.04076834	1.529471168219529
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.04076305	1.5292727077847927
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.0407256	1.5278677279585398
FABRY DISEASE	0.039987059000000005	1.5001605128487754
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.039968699999999996	1.499471753846634
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.039445640000000004	1.4798485563053827
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.03930035	1.474397834837925
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.03930035	1.474397834837925
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.039272100000000004	1.4733380035938224
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.4451708779983423
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.038022569	1.4264604108761272
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.038022569	1.4264604108761272
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.4212340735032172
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.03767925	1.4135804036940351
SLC39A8-CDG	0.037578419	1.4097976127498186
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.037578419	1.4097976127498186
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.037037	1.3894856562064262
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.037037	1.3894856562064262
RCAD (RENAL CYSTS AND DIABETES)	0.037037	1.3894856562064262
APOLIPOPROTEIN A-I DEFICIENCY	0.037037	1.3894856562064262
CANAVAN DISEASE	0.037037	1.3894856562064262
POLAND SYNDROME	0.037037	1.3894856562064262
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.037037	1.3894856562064262
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.037037	1.3894856562064262
LISSENCEPHALY 2; LIS2	0.037037	1.3894856562064262
GASTROINTESTINAL STROMAL TUMOR	0.037037	1.3894856562064262
JEUNE SYNDROME	0.037037	1.3894856562064262
HYPERVITAMINOSIS A, SUSCEPTIBILITY TO	0.037037	1.3894856562064262
SITOSTEROLEMIA	0.037037	1.3894856562064262
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.037037	1.3894856562064262
FIBROSCLEROSIS, MULTIFOCAL	0.037037	1.3894856562064262
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.037037	1.3894856562064262
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.037037	1.3894856562064262
RHYNS SYNDROME	0.037037	1.3894856562064262
ATRANSFERRINEMIA	0.037037	1.3894856562064262
FANCONI ANEMIA	0.037037	1.3894856562064262
MCLEOD SYNDROME; MCLDS	0.037037	1.3894856562064262
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.037037	1.3894856562064262
16P13.11 MICRODELETION SYNDROME	0.037037	1.3894856562064262
BUTYRYLCHOLINESTERASE DEFICIENCY	0.037037	1.3894856562064262
CHRISTIANSON SYNDROME	0.037037	1.3894856562064262
TRICHOTHIODYSTROPHY	0.037037	1.3894856562064262
MYOCLONUS AND ATAXIA	0.037037	1.3894856562064262
CONGENITAL RESPIRATORY-BILIARY FISTULA	0.037037	1.3894856562064262
BURKITT LYMPHOMA	0.037037	1.3894856562064262
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.037037	1.3894856562064262
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.036885480000000005	1.3838012091230125
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.036587399	1.372618357545194
OCULOECTODERMAL SYNDROME; OES	0.036255719000000006	1.3601750008356726
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.036255719000000006	1.3601750008356726
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.036255719000000006	1.3601750008356726
MENTAL RETARDATION, X-LINKED 98; MRX98	0.036220379	1.3588491800864124
SLC35A2-CDG	0.03617967	1.3573219351265478
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.03604598	1.3523064010018013
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.035714300000000004	1.33986304429228
PARTIAL ATRIOVENTRICULAR CANAL	0.035714300000000004	1.33986304429228
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	0.035714300000000004	1.33986304429228
ESSENTIAL THROMBOCYTHEMIA	0.035714300000000004	1.33986304429228
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.035714300000000004	1.33986304429228
HYPOALPHALIPOPROTEINEMIA	0.035714300000000004	1.33986304429228
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4	0.035714300000000004	1.33986304429228
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.035714300000000004	1.33986304429228
JUVENILE POLYPOSIS SYNDROME	0.035714300000000004	1.33986304429228
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.3380603932735493
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.03566625	1.3380603932735493
JUVENILE ABSENCE EPILEPSY	0.03566625	1.3380603932735493
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.03566625	1.3380603932735493
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.3380603932735493
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.035437929	1.3294946683360354
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.035024219	1.3139738618228416
ALPERS-HUTTENLOCHER SYNDROME	0.034820050000000005	1.3063142269457726
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.034820050000000005	1.3063142269457726
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.3063142269457726
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.034627120000000004	1.2990762360811803
MODY	0.0344828	1.2936619052794491
BECKWITH-WIEDEMANN SYNDROME	0.0344828	1.2936619052794491
BECKWITH-WIEDEMANN SYNDROME	0.0344828	1.2936619052794491
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.034069249999999995	1.2781471013502925
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.034069249999999995	1.2781471013502925
DOORS SYNDROME	0.034069249999999995	1.2781471013502925
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.034069249999999995	1.2781471013502925
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.033908069	1.2721002107394708
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.0338934	1.271549886331692
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.03374223	1.2658785699008601
GANGLIOCYTOMA	0.03315414	1.2438156971099095
MENINGIOMA	0.03315414	1.2438156971099095
CHROMOSOME 1P36 DELETION SYNDROME	0.032799519	1.2305116823978763
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.2305116823978763
TUBEROUS SCLEROSIS-1	0.032799519	1.2305116823978763
BENIGN OCCIPITAL EPILEPSY	0.03240334	1.2156485715144298
AICARDI SYNDROME	0.0322581	1.2101997258544839
PEHO SYNDROME	0.0322581	1.2101997258544839
ALG13-CDG	0.0322581	1.2101997258544839
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.0322581	1.2101997258544839
WEST SYNDROME	0.0322581	1.2101997258544839
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.03183498	1.1943258923675906
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.031621939	1.186333414205648
EPILEPSY, PYRIDOXINE-DEPENDENT	0.03158369	1.1848984589753582
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.03158369	1.1848984589753582
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.031516359	1.1823724590639715
3P25.3 MICRODELETION SYNDROME	0.031226909999999997	1.1715134468949702
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.1715134468949702
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.03108052	1.1660214576622556
CHROMOSOME 17Q12 DELETION SYNDROME	0.030948569999999998	1.1610712016389155
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.030533618999999998	1.1455038375832818
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.030533618999999998	1.1455038375832818
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.030462299999999998	1.1428282232647626
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.030195999	1.132837634941372
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.02998188	1.1248047143694773
HYPOADRENOCORTICISM, FAMILIAL	0.029935389	1.1230605510289613
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029165418999999998	1.094174240833501
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.029050318999999998	1.0898561319415994
FUMARASE DEFICIENCY; FMRD	0.02895325	1.086214476754562
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0738622842901084
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0738622842901084
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.02805236	1.0524165521705025
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.02805236	1.0524165521705025
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.027965509	1.0491582370065535
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.02794327	1.0483239153415056
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5	0.027854260000000002	1.044984602809202
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.027777800000000002	1.0421161179623315
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.027777800000000002	1.0421161179623315
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.027777800000000002	1.0421161179623315
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	1.0421161179623315
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	1.0421161179623315
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	1.0421161179623315
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.02777758	1.04210786440928
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.027605868999999998	1.0356659287364969
NEUROLEPTIC MALIGNANT SYNDROME	0.02750357	1.0318280640837374
WALDENSTRÖM MACROGLOBULINEMIA	0.02723386	1.0217095832041996
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	1.0139489923668517
APNEA, OBSTRUCTIVE SLEEP	0.027027	1.0139489923668517
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027027	1.0139489923668517
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.027027	1.0139489923668517
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.027027	1.0139489923668517
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	1.0139489923668517
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.026727849999999997	1.002726036024433
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.02669998	1.0016804609174192
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.02665294	0.999915701210425
MARSILI SYNDROME; MARSIS	0.02665294	0.999915701210425
RIDDLE SYNDROME	0.02665294	0.999915701210425
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1	0.02665294	0.999915701210425
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.026517330000000002	0.9948281360772298
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.026304599999999997	0.9868473254380095
AMISH INFANTILE EPILEPSY SYNDROME	0.025385869999999998	0.9523801127337805
SALT-AND-PEPPER SYNDROME	0.025385869999999998	0.9523801127337805
LEISHMANIASIS	0.02519817	0.9453383313349106
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.02519817	0.9453383313349106
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.025021229	0.9387001861964053
260570 PELGER-HUET-LIKE ANOMALY AND EPISODIC FEVER WITH ABDOMINAL PAIN	0.02500794	0.9382016340759494
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	0.02500794	0.9382016340759494
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.024667039	0.9254123409451228
CARDIOMYOPATHY-HYPOTONIA-LACTIC ACIDOSIS SYNDROME	0.02430827	0.9119527092419197
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.0241153	0.9047132177313181
PRIMARY HYPEROXALURIA TYPE 1	0.0241153	0.9047132177313181
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.024043939	0.9020360277344895
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.024043939	0.9020360277344895
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3; MC3DN3	0.02393269	0.8978623935371379
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.023866949	0.8953960443046225
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.023866949	0.8953960443046225
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.023866949	0.8953960443046225
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.023866949	0.8953960443046225
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.023866949	0.8953960443046225
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.023866949	0.8953960443046225
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.023866949	0.8953960443046225
ABETAL34V AMYLOIDOSIS	0.02350252	0.881724071191097
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.02340734	0.8781532840118511
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.023347699	0.8759157832957616
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.02332553	0.8750840877612301
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.023325529999999997	0.87508408776123
KAGAMI-OGATA SYNDROME	0.023268719	0.8729527577503022
MILLER-DIEKER SYNDROME	0.023268719	0.8729527577503022
COWDEN SYNDROME 6; CWS6	0.023268719	0.8729527577503022
POTOCKI-LUPSKI SYNDROME	0.023268719	0.8729527577503022
COWDEN SYNDROME 5; CWS5	0.023268719	0.8729527577503022
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.023268719	0.8729527577503022
ISOLATED COMPLEX I DEFICIENCY	0.02314288	0.8682317629210407
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0227273	0.8526408012069097
SIRENOMELIA	0.0227273	0.8526408012069097
ACRORENAL-MANDIBULAR SYNDROME	0.0227273	0.8526408012069097
BETHLEM MYOPATHY 1	0.0227273	0.8526408012069097
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0227273	0.8526408012069097
PARIS-TROUSSEAU THROMBOCYTOPENIA	0.0227273	0.8526408012069097
ATROPHODERMA VERMICULATA; AVA	0.0227273	0.8526408012069097
ARTERIES, ANOMALIES OF	0.0227273	0.8526408012069097
LARSEN SYNDROME	0.0227273	0.8526408012069097
THUMB DEFORMITY	0.0227273	0.8526408012069097
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0227273	0.8526408012069097
SILVER-RUSSELL SYNDROME; SRS	0.0227273	0.8526408012069097
CONGENITAL ATRANSFERRINEMIA	0.0227273	0.8526408012069097
HEMANGIOPERICYTOMA, MALIGNANT	0.0227273	0.8526408012069097
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0227273	0.8526408012069097
FATCO SYNDROME	0.0227273	0.8526408012069097
PREPAPILLARY VASCULAR LOOPS	0.0227273	0.8526408012069097
CRANIOFACIOFRONTODIGITAL SYNDROME	0.0227273	0.8526408012069097
VENULAR INSUFFICIENCY, SYSTEMIC	0.0227273	0.8526408012069097
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0227273	0.8526408012069097
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.0227273	0.8526408012069097
GLYCOGEN STORAGE DISEASE DUE TO MUSCLE GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.0227273	0.8526408012069097
RHOMBENCEPHALOSYNAPSIS	0.0227273	0.8526408012069097
AMYLOIDOSIS	0.0227273	0.8526408012069097
WATSON SYNDROME	0.0227273	0.8526408012069097
MUSCULAR HYPERTONIA, LETHAL	0.0227273	0.8526408012069097
COCAINE EMBRYOFETOPATHY	0.0227273	0.8526408012069097
FETAL HYDANTOIN SYNDROME	0.0227273	0.8526408012069097
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.02196765	0.8241416576818613
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.02196765	0.8241416576818613
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.02196765	0.8241416576818613
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.02196765	0.8241416576818613
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.02196765	0.8241416576818613
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.021818019	0.818528078606239
KRABBE DISEASE	0.021818019	0.818528078606239
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.021818019	0.818528078606239
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.021818019	0.818528078606239
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.021818019	0.818528078606239
GITELMAN SYNDROME	0.021818019	0.818528078606239
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.021818019	0.818528078606239
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.021818019	0.818528078606239
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.021546359	0.8083364412337457
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.021356129	0.8011997439747844
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.02129822	0.7990272212308996
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO GAMMA CHAIN DEFICIENCY	0.0212766	0.7982161220628465
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.0212766	0.7982161220628465
FAMILIAL MEDITERRANEAN FEVER; FMF	0.0212766	0.7982161220628465
CAROLI DISEASE, ISOLATED	0.0212766	0.7982161220628465
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE V	0.0212766	0.7982161220628465
STUVE-WIEDEMANN SYNDROME	0.0212766	0.7982161220628465
H SYNDROME	0.0212766	0.7982161220628465
YAO SYNDROME	0.0212766	0.7982161220628465
DOHLE BODIES AND LEUKEMIA	0.0212766	0.7982161220628465
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.0212766	0.7982161220628465
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.0212766	0.7982161220628465
IMMUNODEFICIENCY 9; IMD9	0.0212766	0.7982161220628465
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.0212766	0.7982161220628465
ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY	0.0212766	0.7982161220628465
NAKAJO-NISHIMURA SYNDROME	0.0212766	0.7982161220628465
IMMUNODEFICIENCY 61; IMD61	0.0212766	0.7982161220628465
MAJEED SYNDROME	0.0212766	0.7982161220628465
STÜVE-WIEDEMANN SYNDROME	0.0212766	0.7982161220628465
AUTOINFLAMMATORY SYNDROME, FAMILIAL, BEHCET-LIKE	0.0212766	0.7982161220628465
PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	0.0212766	0.7982161220628465
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.02120304	0.7954564340516539
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.02120304	0.7954564340516539
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.02120304	0.7954564340516539
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.02120304	0.7954564340516539
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.02120304	0.7954564340516539
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.02120304	0.7954564340516539
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.02120304	0.7954564340516539
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.02118759	0.7948768095305428
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.02118759	0.7948768095305428
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.021099659	0.7915779769243413
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.021099659	0.7915779769243413
GRANULOMAS, CONGENITAL CEREBRAL	0.02102928	0.7889376277870421
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.02102928	0.7889376277870421
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02102928	0.7889376277870421
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02102928	0.7889376277870421
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.02102928	0.7889376277870421
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.020928259999999997	0.7851477462904312
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.020928259999999997	0.7851477462904312
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.020928259999999997	0.7851477462904312
CADASIL	0.020743349	0.7782105974345632
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.020740849999999998	0.7781168445751291
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.020740849999999998	0.7781168445751291
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7781168445751291
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7781168445751291
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.02055824	0.7712660203809487
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.020547919999999997	0.7708788537105367
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.020392079	0.765032299341963
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.020392079	0.765032299341963
GENERALIZED GLUCOCORTICOID RESISTANCE SYNDROME	0.020365269999999998	0.764026528870347
GAUCHER DISEASE	0.020032849999999998	0.7515554102096527
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.019684119	0.738472365622496
SNEDDON SYNDROME	0.019616359	0.7359302712826589
ABETA AMYLOIDOSIS, DUTCH TYPE	0.019616359	0.7359302712826589
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.019616359	0.7359302712826589
ENCEPHALITIS LETHARGICA	0.019083059	0.715922908363014
POLYCYTHEMIA VERA	0.01907494	0.7156183147392663
SECONDARY POLYCYTHEMIA	0.01907494	0.7156183147392663
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.01907494	0.7156183147392663
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.018968	0.7116063376332719
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.018968	0.7116063376332719
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.018968	0.7116063376332719
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.018968	0.7116063376332719
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.018968	0.7116063376332719
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.018885039	0.708493960293732
GAUCHER DISEASE TYPE 3	0.01869322	0.7012976498720493
GAUCHER DISEASE TYPE 2	0.01869322	0.7012976498720493
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.01869322	0.7012976498720493
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.01853655	0.6954199946149318
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.01853655	0.6954199946149318
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.01853655	0.6954199946149318
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6954199946149318
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.018000369000000002	0.6753045476664636
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.017813139999999998	0.6682804363743536
LIVER FAILURE, INFANTILE, TRANSIENT	0.017813139999999998	0.6682804363743536
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.017813139999999998	0.6682804363743536
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.017813139999999998	0.6682804363743536
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.017807439	0.6680665568018713
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.017807439	0.6680665568018713
GLYCOGEN STORAGE DISEASE IA	0.01763049	0.661428111534164
NAVAJO NEUROHEPATOPATHY	0.01763049	0.661428111534164
GLYCOGEN STORAGE DISEASE IB	0.01763049	0.661428111534164
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.01748648	0.6560254107390054
PEARSON SYNDROME	0.01745895	0.6549925911230712
AMISH LETHAL MICROCEPHALY	0.01745895	0.6549925911230712
HEMORRHAGIC FEVER-RENAL SYNDROME	0.01745683	0.6549130568845757
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.017292409	0.6487446139469966
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.01726602	0.6477546002584789
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6468309526397246
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6468309526397246
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6468309526397246
269800 SENILE PLAQUE FORMATION	0.0172414	0.6468309526397246
MOTION SICKNESS	0.0172414	0.6468309526397246
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6468309526397246
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6468309526397246
MYOPATHY, CONGENITAL	0.0172414	0.6468309526397246
TRANSSEXUALITY	0.0172414	0.6468309526397246
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.6468309526397246
ERYTHERMALGIA, PRIMARY	0.0172414	0.6468309526397246
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6468309526397246
MOSAIC TRISOMY 15	0.0172414	0.6468309526397246
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.6468309526397246
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6468309526397246
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6468309526397246
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6468309526397246
CARDIAC ARRHYTHMIA	0.0172414	0.6468309526397246
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.6468309526397246
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6468309526397246
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.6468309526397246
CERVICAL RIB	0.0172414	0.6468309526397246
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6468309526397246
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6468309526397246
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6468309526397246
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6468309526397246
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.6468309526397246
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.6468309526397246
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6468309526397246
SICKLE CELL ANEMIA	0.0172414	0.6468309526397246
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6468309526397246
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6468309526397246
ALCOHOL DEPENDENCE	0.0172414	0.6468309526397246
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.6468309526397246
RHEUMATOID ARTHRITIS	0.0172414	0.6468309526397246
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.6468309526397246
THUMBS, CONGENITAL CLASPED	0.0172414	0.6468309526397246
DIASTEMATOMYELIA	0.0172414	0.6468309526397246
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6468309526397246
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.6468309526397246
PALMOMENTAL REFLEX	0.0172414	0.6468309526397246
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.6468309526397246
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6468309526397246
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6468309526397246
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6468309526397246
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6468309526397246
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.017194659	0.6450774102616501
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.017194659	0.6450774102616501
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.017099479	0.6415066230824042
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.017099479	0.6415066230824042
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.017099479	0.6415066230824042
PRIMARY SCLEROSING CHOLANGITIS	0.01708687	0.6410335819441072
RIBOFLAVIN DEFICIENCY	0.01708337	0.6409022754182891
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.017017629	0.6384359261857739
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.017017629	0.6384359261857739
ETHYLMALONIC ENCEPHALOPATHY	0.017017629	0.6384359261857739
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.017017629	0.6384359261857739
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.016649999	0.6246438638753501
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.016476209999999998	0.6181239696423815
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.016476209999999998	0.6181239696423815
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.016476209999999998	0.6181239696423815
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.016301509999999998	0.6115698981965498
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.6115698981965498
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.016301509999999998	0.6115698981965498
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016301509999999998	0.6115698981965498
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.016301509999999998	0.6115698981965498
PERMANENT NEONATAL DIABETES MELLITUS	0.016301509999999998	0.6115698981965498
TRANSIENT NEONATAL DIABETES MELLITUS	0.016301509999999998	0.6115698981965498
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.01610858	0.6043319073319576
PYRIDOXINE-DEPENDENT EPILEPSY	0.01528218	0.5733285607788083
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	0.015180260000000001	0.5695049147469872
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.015043649	0.564379795947408
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.014925399999999998	0.5599435486984203
HAREL-YOON SYNDROME; HAYOS	0.014925399999999998	0.5599435486984203
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.014925399999999998	0.5599435486984203
MENTAL RETARDATION, X-LINKED 41	0.014925399999999998	0.5599435486984203
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.014925399999999998	0.5599435486984203
MYOCLONIC-ATONIC EPILEPSY	0.014925399999999998	0.5599435486984203
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.5599435486984203
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.014925399999999998	0.5599435486984203
NIEMANN-PICK DISEASE TYPE B	0.014925399999999998	0.5599435486984203
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.014925399999999998	0.5599435486984203
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.014432989	0.5414701836456822
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.014432989	0.5414701836456822
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.014432989	0.5414701836456822
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.014432989	0.5414701836456822
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.014432989	0.5414701836456822
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.014432989	0.5414701836456822
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.014432989	0.5414701836456822
LEIGH SYNDROME; LS	0.014432989	0.5414701836456822
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.014432989	0.5414701836456822
PRIMARY HYPEROXALURIA	0.01433827	0.5379166914116942
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.014250339	0.5346178588054926
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.014250339	0.5346178588054926
2P21 MICRODELETION SYNDROME	0.014250339	0.5346178588054926
PRADER-WILLI SYNDROME	0.014240018999999998	0.5342306921350805
CEDNIK SYNDROME	0.014240018999999998	0.5342306921350805
CITRULLINEMIA, CLASSIC	0.014240018999999998	0.5342306921350805
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.014240018999999998	0.5342306921350805
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.014240018999999998	0.5342306921350805
STURGE-WEBER SYNDROME	0.014240018999999998	0.5342306921350805
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.014240018999999998	0.5342306921350805
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.014240018999999998	0.5342306921350805
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.014240018999999998	0.5342306921350805
PITT-HOPKINS-LIKE SYNDROME	0.014171729000000001	0.5316687142356196
MALIGNANT HYPERTHERMIA OF ANESTHESIA	0.01414804	0.5307799941527328
RABIES	0.014076679000000002	0.5281028041559042
VIRAL HEMORRHAGIC FEVER	0.014076679	0.5281028041559042
TAKAYASU ARTERITIS	0.014076679	0.5281028041559042
IMMUNOGLOBULIN A VASCULITIS	0.014076679	0.5281028041559042
BEHÇET DISEASE	0.014076679	0.5281028041559042
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.013891569999999999	0.5211582271022897
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.013891569999999999	0.5211582271022897
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.013891569999999999	0.5211582271022897
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.013891569999999999	0.5211582271022897
MYOPATHY WITH EXERCISE INTOLERANCE, SWEDISH TYPE	0.013891569999999999	0.5211582271022897
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.013891569999999999	0.5211582271022897
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.013891569999999999	0.5211582271022897
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.013891569999999999	0.5211582271022897
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.01370892	0.5143059022621
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.013706719	0.5142233292154357
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.013706719	0.5142233292154357
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.013698599999999998	0.513918735591688
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.013698599999999998	0.513918735591688
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.013698599999999998	0.513918735591688
ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3	0.013698599999999998	0.513918735591688
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.513918735591688
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.013698599999999998	0.513918735591688
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.013698599999999998	0.513918735591688
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.013698599999999998	0.513918735591688
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.013698599999999998	0.513918735591688
FIBROMUSCULAR DYSPLASIA OF ARTERIES	0.013698599999999998	0.513918735591688
AORTIC ANEURYSM, FAMILIAL THORACIC 4	0.013698599999999998	0.513918735591688
DERMOGRAPHISM, FAMILIAL	0.013698599999999998	0.513918735591688
AYMÉ-GRIPP SYNDROME	0.013698599999999998	0.513918735591688
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.013698599999999998	0.513918735591688
ATRIAL FIBRILLATION, FAMILIAL, 1; ATFB1	0.013698599999999998	0.513918735591688
19P13.3 MICRODUPLICATION SYNDROME	0.013698599999999998	0.513918735591688
ANEURYSM OF SINUS OF VALSALVA	0.013698599999999998	0.513918735591688
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.013698599999999998	0.513918735591688
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.013698599999999998	0.513918735591688
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.513918735591688
ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	0.013698599999999998	0.513918735591688
WOLFF-PARKINSON-WHITE SYNDROME	0.013698599999999998	0.513918735591688
WILLIAMS-BEUREN SYNDROME; WBS	0.013698599999999998	0.513918735591688
AMYLOIDOSIS VI	0.013698599999999998	0.513918735591688
JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	0.013698599999999998	0.513918735591688
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.013698599999999998	0.513918735591688
EPILEPSY, HOT WATER, 1	0.013698599999999998	0.513918735591688
ACYS AMYLOIDOSIS	0.013698599999999998	0.513918735591688
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.013698599999999998	0.513918735591688
EISENMENGER SYNDROME	0.013698599999999998	0.513918735591688
MOYAMOYA DISEASE WITH EARLY-ONSET ACHALASIA	0.013698599999999998	0.513918735591688
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.013698599999999998	0.513918735591688
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.013698599999999998	0.513918735591688
PSEUDOXANTHOMA ELASTICUM; PXE	0.013698599999999998	0.513918735591688
CARDIOMYOPATHY, DILATED, 1E	0.013698599999999998	0.513918735591688
AORTA COARCTATION	0.013698599999999998	0.513918735591688
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.513918735591688
APPARENT MINERALOCORTICOID EXCESS	0.013698599999999998	0.513918735591688
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 1	0.013698599999999998	0.513918735591688
WILLIAMS SYNDROME	0.013698599999999998	0.513918735591688
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.013698599999999998	0.513918735591688
COMBINED IMMUNODEFICIENCY DUE TO ZAP70 DEFICIENCY	0.013698599999999998	0.513918735591688
HEPARIN-INDUCED THROMBOCYTOPENIA	0.013698599999999998	0.513918735591688
STROKE, ISCHEMIC	0.013698599999999998	0.513918735591688
FAMILIAL AORTIC DISSECTION	0.013698599999999998	0.513918735591688
ABETA AMYLOIDOSIS, IOWA TYPE	0.013698599999999998	0.513918735591688
ATRIAL FIBRILLATION, FAMILIAL, 3; ATFB3	0.013698599999999998	0.513918735591688
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.513918735591688
%602248 MALIGNANT ATROPHIC PAPULOSIS;;DEGOS DISEASE;;PAPULOSIS, MALIGNANT ATROPHIC	0.013698599999999998	0.513918735591688
SICKLE CELL ANEMIA	0.013698599999999998	0.513918735591688
CINCA SYNDROME	0.01353526	0.5077908476125117
KAWASAKI DISEASE	0.01353526	0.5077908476125117
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.01353526	0.5077908476125117
LEGIONELLOSIS	0.01353526	0.5077908476125117
KERION CELSI	0.01353526	0.5077908476125117
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.01353526	0.5077908476125117
CLASSIC HODGKIN LYMPHOMA	0.01353526	0.5077908476125117
RHEUMATIC FEVER	0.01353526	0.5077908476125117
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.013355530000000001	0.5010480699310045
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.013180830000000001	0.49449399848517295
LETTERER-SIWE DISEASE	0.0131653	0.49391137267204316
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.01302925	0.48880730043274506
MARBURG HEMORRHAGIC FEVER	0.01302925	0.48880730043274506
RELAPSING FEVER	0.01302925	0.48880730043274506
CRIMEAN-CONGO HEMORRHAGIC FEVER	0.01302925	0.48880730043274506
KRABBE DISEASE	0.0129906	0.4873573012262117
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.01241859	0.4658976881310194
HYPERPROLINEMIA, TYPE I	0.012035718999999999	0.4515338421748833
PSEUDO-TORCH SYNDROME 2	0.011505239	0.43163227479889754
INFANTILE LIVER FAILURE SYNDROME 1	0.011505239	0.43163227479889754
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.011494299999999999	0.4312218856314908
BETA-UREIDOPROPIONASE DEFICIENCY	0.011494299999999999	0.4312218856314908
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.011494299999999999	0.4312218856314908
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.011494299999999999	0.4312218856314908
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.4312218856314908
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.011494299999999999	0.4312218856314908
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.011494299999999999	0.4312218856314908
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.011494299999999999	0.4312218856314908
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.011494299999999999	0.4312218856314908
RING CHROMOSOME 14 SYNDROME	0.011494299999999999	0.4312218856314908
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.011494299999999999	0.4312218856314908
PERLMAN SYNDROME	0.011494299999999999	0.4312218856314908
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.011494299999999999	0.4312218856314908
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.011494299999999999	0.4312218856314908
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.011494299999999999	0.4312218856314908
WRINKLY SKIN SYNDROME	0.011494299999999999	0.4312218856314908
DESMOSTEROLOSIS	0.011494299999999999	0.4312218856314908
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.011312309	0.4243942839343052
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.011129659	0.41754195909411557
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.011129659	0.41754195909411557
CONGENITAL DISORDER OF GLYCOSYLATION	0.011129659	0.41754195909411557
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.011129659	0.41754195909411557
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.010963819999999999	0.411320318255505
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.010963819999999999	0.411320318255505
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.010963819999999999	0.411320318255505
NEONATAL INTRAHEPATIC CHOLESTASIS DUE TO CITRIN DEFICIENCY	0.010963819999999999	0.411320318255505
ISOLATED GLYCEROL KINASE DEFICIENCY	0.010958119	0.4111064386830226
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.010958119	0.4111064386830226
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.010958119	0.4111064386830226
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.010958119	0.4111064386830226
SUDDEN CARDIAC FAILURE, INFANTILE	0.010958119	0.4111064386830226
ISOVALERIC ACIDEMIA	0.010958119	0.4111064386830226
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.010958119	0.4111064386830226
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.010958119	0.4111064386830226
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.010958119	0.4111064386830226
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.01083013	0.40630478413075855
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 3	0.01077359	0.40418362099654376
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 2	0.01077359	0.40418362099654376
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5	0.01058824	0.39723000255072305
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	0.01058824	0.39723000255072305
TYROSINEMIA, TYPE I; TYRSN1	0.01058824	0.39723000255072305
GLYCOGEN STORAGE DISEASE VI	0.01058824	0.39723000255072305
HAWKINSINURIA	0.010416700000000001	0.3907944821396302
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.010416700000000001	0.3907944821396302
GLUCOSE/GALACTOSE MALABSORPTION; GGM	0.010416700000000001	0.3907944821396302
LACTASE DEFICIENCY, CONGENITAL	0.010416700000000001	0.3907944821396302
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.010416700000000001	0.3907944821396302
HAWKINSINURIA	0.010416700000000001	0.3907944821396302
HYPEROXALURIA, PRIMARY, TYPE I; HP1	0.010416700000000001	0.3907944821396302
MEDIUM CHAIN 3-KETOACYL-COA THIOLASE DEFICIENCY	0.010416700000000001	0.3907944821396302
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.010416700000000001	0.3907944821396302
MICROVILLUS INCLUSION DISEASE	0.010416700000000001	0.3907944821396302
NORRIE DISEASE	0.010345339	0.3881172921428014
ATYPICAL TERATOID RHABDOID TUMOR	0.010345339	0.3881172921428014
SYSTEMIC SCLEROSIS	0.010345339	0.3881172921428014
FAMILIAL COLORECTAL CANCER TYPE X	0.010345339	0.3881172921428014
BERNARD-SOULIER SYNDROME	0.010345339	0.3881172921428014
MALAN OVERGROWTH SYNDROME	0.010345339	0.3881172921428014
EPISODIC ATAXIA, TYPE 6	0.010345339	0.3881172921428014
SNEDDON SYNDROME	0.010345339	0.3881172921428014
PHACE ASSOCIATION	0.010345339	0.3881172921428014
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.010345339	0.3881172921428014
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.010345339	0.3881172921428014
SUBEPENDYMOMA	0.010345339	0.3881172921428014
EPENDYMOMA	0.010345339	0.3881172921428014
EPISODIC ATAXIA TYPE 6	0.010345339	0.3881172921428014
CYCLIC VOMITING SYNDROME	0.010345339	0.3881172921428014
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.010345339	0.3881172921428014
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.010345339	0.3881172921428014
DISTAL 16P11.2 MICRODELETION SYNDROME	0.010345339	0.3881172921428014
BENIGN FAMILIAL INFANTILE EPILEPSY	0.010345339	0.3881172921428014
SAETHRE-CHOTZEN SYNDROME	0.010345339	0.3881172921428014
HARTNUP DISEASE	0.010345339	0.3881172921428014
LYNCH SYNDROME	0.010345339	0.3881172921428014
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.010250159	0.3845465049635555
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.010250159	0.3845465049635555
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.010250159	0.3845465049635555
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.010250159	0.3845465049635555
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.010250159	0.3845465049635555
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.010250159	0.3845465049635555
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.010250159	0.3845465049635555
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.010250159	0.3845465049635555
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.010250159	0.3845465049635555
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.010250159	0.3845465049635555
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.010250159	0.3845465049635555
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.010250159	0.3845465049635555
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.010250159	0.3845465049635555
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.010250159	0.3845465049635555
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.010250159	0.3845465049635555
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.010250159	0.3845465049635555
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.010250159	0.3845465049635555
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.010250159	0.3845465049635555
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.010250159	0.3845465049635555
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.010250159	0.3845465049635555
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.010250159	0.3845465049635555
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.010250159	0.3845465049635555
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.010250159	0.3845465049635555
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.010250159	0.3845465049635555
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.010250159	0.3845465049635555
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.010250159	0.3845465049635555
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.010250159	0.3845465049635555
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.010250159	0.3845465049635555
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.010250159	0.3845465049635555
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.010250159	0.3845465049635555
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.010250159	0.3845465049635555
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.010250159	0.3845465049635555
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.010250159	0.3845465049635555
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.010250159	0.3845465049635555
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.010250159	0.3845465049635555
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.010250159	0.3845465049635555
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.010250159	0.3845465049635555
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.010250159	0.3845465049635555
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.010250159	0.3845465049635555
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.010250159	0.3845465049635555
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.010250159	0.3845465049635555
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.010250159	0.3845465049635555
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.010250159	0.3845465049635555
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.010250159	0.3845465049635555
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.010250159	0.3845465049635555
RAYNAUD-CLAES SYNDROME; MRXSRC	0.010250159	0.3845465049635555
GLYCINE ENCEPHALOPATHY; GCE	0.009975379	0.3742378172023329
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.009975379	0.3742378172023329
HYPEREKPLEXIA 4; HKPX4	0.009975379	0.3742378172023329
FADD-RELATED IMMUNODEFICIENCY	0.009975379	0.3742378172023329
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.009975379	0.3742378172023329
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.009975379	0.3742378172023329
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.009975379	0.3742378172023329
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.009975379	0.3742378172023329
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.009975379	0.3742378172023329
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.009975379	0.3742378172023329
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.009975379	0.3742378172023329
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.009975379	0.3742378172023329
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.009975379	0.3742378172023329
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.009975379	0.3742378172023329
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.009975379	0.3742378172023329
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.009975379	0.3742378172023329
PITT-HOPKINS SYNDROME	0.009975379	0.3742378172023329
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.009975379	0.3742378172023329
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.009975379	0.3742378172023329
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.009975379	0.3742378172023329
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.009975379	0.3742378172023329
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.009975379	0.3742378172023329
GLUTAMINE DEFICIENCY, CONGENITAL	0.009975379	0.3742378172023329
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.009975379	0.3742378172023329
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.009975379	0.3742378172023329
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.009975379	0.3742378172023329
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.009839329	0.36913374496303486
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.00980392	0.36780533559940887
NEUROFIBROMATOSIS TYPE 2	0.00980392	0.36780533559940887
BLACKFAN-DIAMOND ANEMIA	0.00980392	0.36780533559940887
SPINOCEREBELLAR ATAXIA TYPE 36	0.00980392	0.36780533559940887
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.00980392	0.36780533559940887
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5	0.00980392	0.36780533559940887
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00980392	0.36780533559940887
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.00980392	0.36780533559940887
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4	0.00980392	0.36780533559940887
EPISODIC ATAXIA TYPE 7	0.00980392	0.36780533559940887
PEROXISOME BIOGENESIS DISORDER 14B	0.00980392	0.36780533559940887
EPISODIC ATAXIA, TYPE 2	0.00980392	0.36780533559940887
EPISODIC ATAXIA WITH SLURRED SPEECH	0.00980392	0.36780533559940887
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.00980392	0.36780533559940887
CLASSICAL EHLERS-DANLOS SYNDROME	0.00980392	0.36780533559940887
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00980392	0.36780533559940887
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.00980392	0.36780533559940887
ACROMEGALY	0.00980392	0.36780533559940887
FAMILIAL PAROXYSMAL ATAXIA	0.00980392	0.36780533559940887
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.00980392	0.36780533559940887
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.00980392	0.36780533559940887
ARACHNOIDITIS	0.00980392	0.36780533559940887
SOMATOMAMMOTROPINOMA	0.00980392	0.36780533559940887
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.009800679	0.36768374575650137
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.009800679	0.36768374575650137
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00970874	0.36423454842016306
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00970874	0.36423454842016306
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.00970874	0.36423454842016306
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00970874	0.36423454842016306
ROSAÏ-DORFMAN DISEASE	0.009649099000000001	0.3619970477040736
NIPAH VIRUS DISEASE	0.009649099000000001	0.3619970477040736
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.009649099000000001	0.3619970477040736
LUJO HEMORRHAGIC FEVER	0.009649099000000001	0.3619970477040736
CENTRAL DIABETES INSIPIDUS	0.009649099000000001	0.3619970477040736
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.009649099	0.36199704770407354
CRYPTOCOCCOSIS	0.009649099	0.36199704770407354
SCRUB TYPHUS	0.009649099	0.36199704770407354
RIFT VALLEY FEVER	0.009649099	0.36199704770407354
GRANULOMATOSIS WITH POLYANGIITIS	0.009649099	0.36199704770407354
LASSA FEVER	0.009649099	0.36199704770407354
NOCARDIOSIS	0.009649099	0.36199704770407354
POSTENCEPHALITIC PARKINSONISM	0.009649099	0.36199704770407354
ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	0.00943396	0.35392586065894044
IMMUNODEFICIENCY 44	0.00943396	0.35392586065894044
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 2; CEMCOX2	0.00943396	0.35392586065894044
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.00943396	0.35392586065894044
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.00943396	0.35392586065894044
HELLP SYNDROME	0.00929791	0.34882178841964234
CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE III	0.00929791	0.34882178841964234
PREECLAMPSIA	0.00929791	0.34882178841964234
MEDULLOBLASTOMA	0.00929791	0.34882178841964234
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00925926	0.3473717892131089
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.3473717892131089
MICROHYDRANENCEPHALY; MHAC	0.00925926	0.3473717892131089
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00925926	0.3473717892131089
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.00925926	0.3473717892131089
ROIFMAN-CHITAYAT SYNDROME	0.00925926	0.3473717892131089
HYDROXYLYSINURIA	0.00925926	0.3473717892131089
PAINE SYNDROME	0.00925926	0.3473717892131089
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.3473717892131089
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00925926	0.3473717892131089
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.3473717892131089
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.00925926	0.3473717892131089
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.00925926	0.3473717892131089
MERRF	0.00925926	0.3473717892131089
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00925926	0.3473717892131089
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00925926	0.3473717892131089
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.00925926	0.3473717892131089
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.00925926	0.3473717892131089
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.3473717892131089
CARNOSINASE DEFICIENCY	0.00925926	0.3473717892131089
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.00925926	0.3473717892131089
XQ12-Q13.3 DUPLICATION SYNDROME	0.00925926	0.3473717892131089
CARNOSINEMIA	0.00925926	0.3473717892131089
X-LINKED ADRENOLEUKODYSTROPHY	0.00916422	0.3438062542948958
RHABDOID TUMOR	0.00910768	0.341685091160681
AUTOIMMUNE HEMOLYTIC ANEMIA	0.00910768	0.341685091160681
YELLOW FEVER	0.00910768	0.341685091160681
HODGKIN LYMPHOMA	0.00910768	0.341685091160681
AMERICAN TRYPANOSOMIASIS	0.00910768	0.341685091160681
PONTIAC FEVER	0.00910768	0.341685091160681
HUGHES-STOVIN SYNDROME	0.00910768	0.341685091160681
AUTOIMMUNE HEMOLYTIC ANEMIA, WARM TYPE	0.00910768	0.341685091160681
TYPHOID	0.00910768	0.341685091160681
LYME DISEASE	0.00910768	0.341685091160681
PLAGUE	0.00910768	0.341685091160681
MAJEED SYNDROME	0.00910768	0.341685091160681
PAROXYSMAL COLD HEMOGLOBINURIA	0.00910768	0.341685091160681
POSTORGASMIC ILLNESS SYNDROME	0.00910768	0.341685091160681
GIANT CELL ARTERITIS	0.00910768	0.341685091160681
FAMILIAL COLD URTICARIA	0.00910768	0.341685091160681
RAT-BITE FEVER	0.00910768	0.341685091160681
BABESIOSIS	0.00910768	0.341685091160681
HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA	0.00910768	0.341685091160681
DENGUE FEVER	0.00910768	0.341685091160681
PMM2-CDG	0.008194329	0.3074196778285593
RECURRENT ACUTE PANCREATITIS	0.008194329	0.3074196778285593
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.008194329	0.3074196778285593
BETA-THALASSEMIA MAJOR	0.007652910000000001	0.28710772128516676
CORTICOSTEROID-SENSITIVE ASEPTIC ABSCESS SYNDROME	0.007652910000000001	0.28710772128516676
BUDD-CHIARI SYNDROME	0.007652910000000001	0.28710772128516676
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS	0.007652910000000001	0.28710772128516676
STEVENS-JOHNSON SYNDROME	0.007652910000000001	0.28710772128516676
SEVERE COMBINED IMMUNODEFICIENCY DUE TO COMPLETE RAG1/2 DEFICIENCY	0.007652910000000001	0.28710772128516676
ADULT-ONSET STILL DISEASE	0.007652910000000001	0.28710772128516676
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.2845100655268335
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.0075836689999999995	0.2845100655268335
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.0075836689999999995	0.2845100655268335
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.2845100655268335
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.0075836689999999995	0.2845100655268335
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.0075836689999999995	0.2845100655268335
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.0075836689999999995	0.2845100655268335
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.0075836689999999995	0.2845100655268335
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.0075836689999999995	0.2845100655268335
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.0075836689999999995	0.2845100655268335
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.0075836689999999995	0.2845100655268335
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.0075836689999999995	0.2845100655268335
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.0075836689999999995	0.2845100655268335
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.0075836689999999995	0.2845100655268335
3-HYDROXYISOBUTYRIC ACIDURIA	0.0075836689999999995	0.2845100655268335
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.0075836689999999995	0.2845100655268335
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.007390739	0.2772720746622412
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.007390739	0.2772720746622412
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.007390739	0.2772720746622412
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.007390739	0.2772720746622412
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.007390739	0.2772720746622412
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.007390739	0.2772720746622412
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.007390739	0.2772720746622412
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.007390739	0.2772720746622412
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.007390739	0.2772720746622412
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.007390739	0.2772720746622412
PERRAULT SYNDROME 5; PRLTS5	0.007390739	0.2772720746622412
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.007390739	0.2772720746622412
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.007208089000000001	0.2704197498220516
SMITH-KINGSMORE SYNDROME; SKS	0.007208089000000001	0.2704197498220516
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.007208089000000001	0.2704197498220516
GALACTOSEMIA	0.007208089000000001	0.2704197498220516
TENORIO SYNDROME; TNORS	0.007208089000000001	0.2704197498220516
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.007208089000000001	0.2704197498220516
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.007208089000000001	0.2704197498220516
OCULODENTODIGITAL DYSPLASIA	0.007208089000000001	0.2704197498220516
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.007208089000000001	0.2704197498220516
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.007208089000000001	0.2704197498220516
HOLOPROSENCEPHALY	0.007208089000000001	0.2704197498220516
SHASHI-PENA SYNDROME; SHAPNS	0.007208089000000001	0.2704197498220516
VISCERAL STEATOSIS, CONGENITAL	0.007208089000000001	0.2704197498220516
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.007208089000000001	0.2704197498220516
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.007208089000000001	0.2704197498220516
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.007208089000000001	0.2704197498220516
SIMPSON-GOLABI-BEHMEL SYNDROME	0.007208089000000001	0.2704197498220516
MENKES DISEASE	0.007208089000000001	0.2704197498220516
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.007208089000000001	0.2704197498220516
MIRAGE SYNDROME; MIRAGE	0.007208089000000001	0.2704197498220516
SOTOS SYNDROME	0.007208089000000001	0.2704197498220516
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.007208089000000001	0.2704197498220516
TIMOTHY SYNDROME; TS	0.007208089000000001	0.2704197498220516
PITUITARY STALK INTERRUPTION SYNDROME	0.007208089000000001	0.2704197498220516
MEHMO SYNDROME; MEHMO	0.007208089000000001	0.2704197498220516
HOLOPROSENCEPHALY 1; HPE1	0.007208089000000001	0.2704197498220516
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.007208089000000001	0.2704197498220516
ENDOCARDIAL FIBROELASTOSIS	0.007208089000000001	0.2704197498220516
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.007208089000000001	0.2704197498220516
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.007208089000000001	0.2704197498220516
FRUCTOSE AND GALACTOSE INTOLERANCE	0.007208089000000001	0.2704197498220516
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.00704225	0.26419810898344104
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00704225	0.26419810898344104
1Q44 MICRODELETION SYNDROME	0.00704225	0.26419810898344104
PHENFORMIN 4-HYDROXYLATION	0.00704225	0.26419810898344104
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.00704225	0.26419810898344104
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.00704225	0.26419810898344104
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.26419810898344104
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.26419810898344104
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.26419810898344104
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.26419810898344104
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.00704225	0.26419810898344104
OROFACIODIGITAL SYNDROME TYPE 2	0.00704225	0.26419810898344104
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.00704225	0.26419810898344104
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00704225	0.26419810898344104
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.26419810898344104
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.26419810898344104
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00704225	0.26419810898344104
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00704225	0.26419810898344104
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 4; CEMCOX4	0.00704225	0.26419810898344104
X SMALL RINGS	0.00704225	0.26419810898344104
OLIVER SYNDROME	0.00704225	0.26419810898344104
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00704225	0.26419810898344104
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00704225	0.26419810898344104
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.26419810898344104
ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	0.00704225	0.26419810898344104
207720 APNEA, CENTRAL SLEEP;;SLEEP APNEA, LETHAL CENTRAL	0.00704225	0.26419810898344104
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.26419810898344104
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.00704225	0.26419810898344104
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.00704225	0.26419810898344104
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.00704225	0.26419810898344104
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.00704225	0.26419810898344104
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00704225	0.26419810898344104
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.00704225	0.26419810898344104
CONGENITAL CATARACT-HYPERTROPHIC CARDIOMYOPATHY-MITOCHONDRIAL MYOPATHY SYNDROME	0.00704225	0.26419810898344104
GRACILE SYNDROME	0.00704225	0.26419810898344104
PELGER-HUET ANOMALY; PHA	0.00704225	0.26419810898344104
W SYNDROME	0.00704225	0.26419810898344104
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.00704225	0.26419810898344104
HALLERMANN-STREIFF SYNDROME; HSS	0.00704225	0.26419810898344104
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.00704225	0.26419810898344104
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.00704225	0.26419810898344104
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.00704225	0.26419810898344104
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.26419810898344104
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.00704225	0.26419810898344104
SARCOSINEMIA	0.00704225	0.26419810898344104
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.00704225	0.26419810898344104
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.00704225	0.26419810898344104
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.00704225	0.26419810898344104
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.00704225	0.26419810898344104
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.00704225	0.26419810898344104
MYOPATHY, MITOCHONDRIAL, LETHAL INFANTILE	0.00704225	0.26419810898344104
SUCCINIC ACIDEMIA	0.00704225	0.26419810898344104
LYSINURIC PROTEIN INTOLERANCE; LPI	0.00684932	0.25696011811884867
MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD	0.00684932	0.25696011811884867
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00684932	0.25696011811884867
GLYCOGEN STORAGE DISEASE DUE TO LACTATE DEHYDROGENASE DEFICIENCY	0.00684932	0.25696011811884867
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.00684932	0.25696011811884867
GLYCOGEN STORAGE DISEASE XI; GSD11	0.00684932	0.25696011811884867
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00684932	0.25696011811884867
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.00684932	0.25696011811884867
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00684932	0.25696011811884867
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.00684932	0.25696011811884867
LEBER OPTIC ATROPHY AND DYSTONIA	0.00684932	0.25696011811884867
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.00684932	0.25696011811884867
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.00684932	0.25696011811884867
AUTOSOMAL DOMINANT MITOCHONDRIAL MYOPATHY WITH EXERCISE INTOLERANCE	0.00684932	0.25696011811884867
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.00684932	0.25696011811884867
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.00684932	0.25696011811884867
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00684932	0.25696011811884867
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.00684932	0.25696011811884867
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.00684932	0.25696011811884867
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.00684932	0.25696011811884867
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.00684932	0.25696011811884867
MITOCHONDRIAL DNA-RELATED PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00684932	0.25696011811884867
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	0.00684932	0.25696011811884867
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24; MC1DN24	0.00684932	0.25696011811884867
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.00684932	0.25696011811884867
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29; MC1DN29	0.00684932	0.25696011811884867
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.00684932	0.25696011811884867
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHORYLASE KINASE DEFICIENCY	0.00666667	0.2501077932786591
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2; HHF2	0.00666667	0.2501077932786591
LEPRECHAUNISM	0.00666667	0.2501077932786591
PROPIONIC ACIDEMIA	0.00666667	0.2501077932786591
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.00666667	0.2501077932786591
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN DEBRANCHING ENZYME DEFICIENCY	0.00666667	0.2501077932786591
GROWTH HORMONE INSENSITIVITY SYNDROME	0.00666667	0.2501077932786591
CONGENITAL ISOLATED HYPERINSULINISM	0.00666667	0.2501077932786591
POLYENDOCRINE-POLYNEUROPATHY SYNDROME	0.00666667	0.2501077932786591
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.00666667	0.2501077932786591
HISTIDINURIA-RENAL TUBULAR DEFECT SYNDROME	0.00666667	0.2501077932786591
COSTELLO SYNDROME; CSTLO	0.00666667	0.2501077932786591
CLASSIC GALACTOSEMIA	0.00666667	0.2501077932786591
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.00666667	0.2501077932786591
SHORT STATURE DUE TO PARTIAL GHR DEFICIENCY	0.00666667	0.2501077932786591
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.00666667	0.2501077932786591
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.00666667	0.2501077932786591
GLYCOGEN STORAGE DISEASE DUE TO LIVER GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.00666667	0.2501077932786591
POST-TRAUMATIC PITUITARY DEFICIENCY	0.00666667	0.2501077932786591
NEONATAL HEMOCHROMATOSIS	0.00666667	0.2501077932786591
PITUITARY DWARFISM WITH SMALL SELLA TURCICA	0.00666667	0.2501077932786591
MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	0.00666667	0.2501077932786591
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.00666667	0.2501077932786591
MPI-CDG	0.00666667	0.2501077932786591
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.00666667	0.2501077932786591
PHOSPHOENOLPYRUVATE CARBOXYKINASE 2, MITOCHONDRIAL	0.00666667	0.2501077932786591
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.00666667	0.2501077932786591
HEMOCHROMATOSIS, NEONATAL	0.00666667	0.2501077932786591
LARON SYNDROME	0.00666667	0.2501077932786591
ORTHOSTATIC HYPOTENSION 2; ORTHYP2	0.00666667	0.2501077932786591
PANHYPOPITUITARISM	0.00666667	0.2501077932786591
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.00666667	0.2501077932786591
ORNITHINE TRANSCARBAMYLASE DEFICIENCY	0.00666667	0.2501077932786591
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.00666667	0.2501077932786591
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.00666667	0.2501077932786591
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00666667	0.2501077932786591
WYBURN-MASON SYNDROME	0.005917759	0.2220115356909708
NARP SYNDROME	0.005917759	0.2220115356909708
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.005917759	0.2220115356909708
ADIPOSIS DOLOROSA	0.005917759	0.2220115356909708
CRANIOPHARYNGIOMA	0.005917759	0.2220115356909708
PARIETAL FORAMINA	0.005917759	0.2220115356909708
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.005917759	0.2220115356909708
LHERMITTE-DUCLOS DISEASE	0.005917759	0.2220115356909708
EBOLA HEMORRHAGIC FEVER	0.005917759	0.2220115356909708
PAPILLOMA OF CHOROID PLEXUS	0.005917759	0.2220115356909708
GLIOBLASTOMA	0.005917759	0.2220115356909708
L1 SYNDROME	0.005917759	0.2220115356909708
OPTIC PATHWAY GLIOMA	0.005917759	0.2220115356909708
TSH-SECRETING PITUITARY ADENOMA	0.005917759	0.2220115356909708
15Q OVERGROWTH SYNDROME	0.005917759	0.2220115356909708
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.005917759	0.2220115356909708
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.005917759	0.2220115356909708
NEUROFIBROMATOSIS TYPE 1	0.005917759	0.2220115356909708
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.005917759	0.2220115356909708
NON-FUNCTIONING PITUITARY ADENOMA	0.005917759	0.2220115356909708
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.005917759	0.2220115356909708
CRANIOSYNOSTOSIS 2	0.005917759	0.2220115356909708
PINEOBLASTOMA	0.005917759	0.2220115356909708
NEUROFIBROMATOSIS, TYPE II	0.005917759	0.2220115356909708
PROLACTINOMA	0.005917759	0.2220115356909708
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.005917759	0.2220115356909708
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.005917759	0.2220115356909708
COLD AGGLUTININ DISEASE	0.00537634	0.2016995791475783
PRIMARY UNILATERAL ADRENAL HYPERPLASIA	0.00537634	0.2016995791475783
PITUITARY CARCINOMA	0.00537634	0.2016995791475783
FAMILIAL HYPERALDOSTERONISM TYPE II	0.00537634	0.2016995791475783
MANGANESE POISONING	0.00537634	0.2016995791475783
TURCOT SYNDROME WITH POLYPOSIS	0.00537634	0.2016995791475783
FAMILIAL HYPERALDOSTERONISM TYPE I	0.00537634	0.2016995791475783
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.00537634	0.2016995791475783
PINEOCYTOMA	0.00537634	0.2016995791475783
ACROOSTEOLYSIS DOMINANT TYPE	0.00537634	0.2016995791475783
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.00537634	0.2016995791475783
OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	0.00537634	0.2016995791475783
ADENOHYPOPHYSITIS	0.00537634	0.2016995791475783
PANHYPOPHYSITIS	0.00537634	0.2016995791475783
CENTRAL NEUROCYTOMA	0.00537634	0.2016995791475783
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.00537634	0.2016995791475783
PRIMARY PARATHYROID HYPERPLASIA	0.00537634	0.2016995791475783
SCLEROSTEOSIS 1; SOST1	0.00537634	0.2016995791475783
ALPORT SYNDROME	0.00537634	0.2016995791475783
JUVENILE TEMPORAL ARTERITIS	0.00537634	0.2016995791475783
ENAMEL HYPOPLASIA, CATARACTS, AND AQUEDUCTAL STENOSIS	0.00537634	0.2016995791475783
DRUG-INDUCED AUTOIMMUNE HEMOLYTIC ANEMIA	0.00537634	0.2016995791475783
CHIARI MALFORMATION TYPE I	0.00537634	0.2016995791475783
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.00537634	0.2016995791475783
HYPER-IGD SYNDROME	0.00537634	0.2016995791475783
MYXOPAPILLARY EPENDYMOMA	0.00537634	0.2016995791475783
SOLAR URTICARIA	0.00537634	0.2016995791475783
PITUICYTOMA	0.00537634	0.2016995791475783
EPISODIC ATAXIA TYPE 1	0.00537634	0.2016995791475783
PRIMARY FAMILIAL POLYCYTHEMIA	0.00537634	0.2016995791475783
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.00537634	0.2016995791475783
SYDENHAM CHOREA	0.00537634	0.2016995791475783
FAMILIAL HYPERALDOSTERONISM TYPE III	0.00537634	0.2016995791475783
ADRENOCORTICAL CARCINOMA WITH PURE ALDOSTERONE HYPERSECRETION	0.00537634	0.2016995791475783
SYSTEMIC MASTOCYTOSIS	0.00537634	0.2016995791475783
IDIOPATHIC PANUVEITIS	0.00537634	0.2016995791475783
MACULOPAPULAR CUTANEOUS MASTOCYTOSIS	0.00537634	0.2016995791475783
GLUTAMATE MONOSODIUM SENSITIVITY	0.00537634	0.2016995791475783
SUSAC SYNDROME	0.00537634	0.2016995791475783
THYMIC TUMOR	0.00537634	0.2016995791475783
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.00537634	0.2016995791475783
SEVERE HEMOPHILIA A	0.00537634	0.2016995791475783
TEMPI SYNDROME	0.00537634	0.2016995791475783
HEMANGIOBLASTOMA	0.00537634	0.2016995791475783
CUTANEOUS MASTOCYTOMA	0.00537634	0.2016995791475783
INDOLENT SYSTEMIC MASTOCYTOSIS	0.00537634	0.2016995791475783
BRUNNER SYNDROME; BRNRS	0.00537634	0.2016995791475783
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.00537634	0.2016995791475783
PARKES WEBER SYNDROME	0.00537634	0.2016995791475783
PARATHYROID CARCINOMA	0.00537634	0.2016995791475783
INTERNAL CAROTID AGENESIS	0.00537634	0.2016995791475783
PERINEURAL CYST	0.00537634	0.2016995791475783
CARNEY TRIAD	0.00537634	0.2016995791475783
CUTANEOUS MASTOCYTOSIS	0.00537634	0.2016995791475783
FUNCTIONING GONADOTROPIC ADENOMA	0.00537634	0.2016995791475783
EPISODIC ATAXIA, TYPE 1; EA1	0.00537634	0.2016995791475783
PRIMARY CILIARY DYSKINESIA	0.00537634	0.2016995791475783
CAMURATI-ENGELMANN DISEASE	0.00537634	0.2016995791475783
EPISODIC ATAXIA, TYPE 3	0.00537634	0.2016995791475783
DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE	0.00537634	0.2016995791475783
ECTOPIC ALDOSTERONE-PRODUCING TUMOR	0.00537634	0.2016995791475783
CROUZON DISEASE	0.00537634	0.2016995791475783
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.00537634	0.2016995791475783
PAPILLARY TUMOR OF THE PINEAL REGION	0.00537634	0.2016995791475783
CUSHING DISEASE	0.00537634	0.2016995791475783
MIDDLE EAR NEUROENDOCRINE TUMOR	0.00537634	0.2016995791475783
IMMUNODEFICIENCY 47	0.0044629890000000005	0.1674341658154565
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.0044629890000000005	0.1674341658154565
SRD5A3-CDG	0.0044629890000000005	0.1674341658154565
CHOREOACANTHOCYTOSIS	0.0044629890000000005	0.1674341658154565
ISOLATED BILIARY ATRESIA	0.0044629890000000005	0.1674341658154565
PREECLAMPSIA/ECLAMPSIA 1	0.0044629890000000005	0.1674341658154565
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.0044629890000000005	0.1674341658154565
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.0044629890000000005	0.1674341658154565
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.0044629890000000005	0.1674341658154565
17Q12 MICRODELETION SYNDROME	0.0044629890000000005	0.1674341658154565
LATHOSTEROLOSIS	0.0044629890000000005	0.1674341658154565
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.0044629890000000005	0.1674341658154565
CONGENITAL TOXOPLASMOSIS	0.0044629890000000005	0.1674341658154565
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.0044629890000000005	0.1674341658154565
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.0044629890000000005	0.1674341658154565
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.0044629890000000005	0.1674341658154565
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.0044629890000000005	0.1674341658154565
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.0044629890000000005	0.1674341658154565
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.0044629890000000005	0.1674341658154565
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.0044629890000000005	0.1674341658154565
DDOST-CDG	0.0044629890000000005	0.1674341658154565
ATAXIA-TELANGIECTASIA	0.0044629890000000005	0.1674341658154565
OROFACIODIGITAL SYNDROME TYPE 1	0.0044629890000000005	0.1674341658154565
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.0044629890000000005	0.1674341658154565
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.0044629890000000005	0.1674341658154565
CLASSIC HOMOCYSTINURIA	0.0044629890000000005	0.1674341658154565
COG5-CDG	0.0044629890000000005	0.1674341658154565
RETINITIS PIGMENTOSA 59; RP59	0.0044629890000000005	0.1674341658154565
ALG11-CDG	0.0044629890000000005	0.1674341658154565
SIALURIA	0.0044629890000000005	0.1674341658154565
COACH SYNDROME	0.0044629890000000005	0.1674341658154565
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.0044629890000000005	0.1674341658154565
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.0044629890000000005	0.1674341658154565
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.0044629890000000005	0.1674341658154565
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.004329299	0.16241863169070997
XYLOSIDASE DEFICIENCY	0.004329299	0.16241863169070997
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.004329299	0.16241863169070997
ASPARTYLGLUCOSAMINURIA; AGU	0.004329299	0.16241863169070997
EPILEPSY-TELANGIECTASIA	0.004329299	0.16241863169070997
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.004329299	0.16241863169070997
HYPERLEUCINE-ISOLEUCINEMIA	0.004329299	0.16241863169070997
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.004329299	0.16241863169070997
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.004329299	0.16241863169070997
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.004329299	0.16241863169070997
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.004329299	0.16241863169070997
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.004329299	0.16241863169070997
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.004329299	0.16241863169070997
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.004329299	0.16241863169070997
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.004329299	0.16241863169070997
BARAITSER-WINTER SYNDROME 1; BRWS1	0.004329299	0.16241863169070997
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.004329299	0.16241863169070997
SALLA DISEASE	0.004329299	0.16241863169070997
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.004329299	0.16241863169070997
EMANUEL SYNDROME	0.004329299	0.16241863169070997
ICHTHYOSIS AND MALE HYPOGONADISM	0.004329299	0.16241863169070997
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.004329299	0.16241863169070997
NEURONAL CEROID LIPOFUSCINOSIS	0.004329299	0.16241863169070997
GAPO SYNDROME; GAPOS	0.004329299	0.16241863169070997
CHROMOSOME 10Q26 DELETION SYNDROME	0.004329299	0.16241863169070997
NEPHROGENIC DIABETES INSIPIDUS	0.004272759	0.16029746855649524
PORPHYRIA	0.004272759	0.16029746855649524
CHÉDIAK-HIGASHI SYNDROME	0.004272759	0.16029746855649524
XERODERMA PIGMENTOSUM	0.004272759	0.16029746855649524
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.004272759	0.16029746855649524
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.004272759	0.16029746855649524
MICROSPORIDIOSIS	0.004272759	0.16029746855649524
MIXED CONNECTIVE TISSUE DISEASE	0.004272759	0.16029746855649524
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.004272759	0.16029746855649524
HYPOPHOSPHATASIA, INFANTILE	0.004272759	0.16029746855649524
GRISCELLI SYNDROME TYPE 2	0.004272759	0.16029746855649524
LYMPHANGIOLEIOMYOMATOSIS	0.004272759	0.16029746855649524
FAMILIAL MEDITERRANEAN FEVER	0.004272759	0.16029746855649524
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.004272759	0.16029746855649524
GRISCELLI SYNDROME	0.004272759	0.16029746855649524
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.004272759	0.16029746855649524
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.004272759	0.16029746855649524
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.004272759	0.16029746855649524
WHIPPLE DISEASE	0.004272759	0.16029746855649524
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.00392157	0.14712220927206404
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.00392157	0.14712220927206404
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.00392157	0.14712220927206404
PULMONARY FIBROSIS-HEPATIC HYPERPLASIA-BONE MARROW HYPOPLASIA SYNDROME	0.00392157	0.14712220927206404
NEUROENDOCRINE TUMOR OF THE COLON	0.00392157	0.14712220927206404
NEUROENDOCRINE TUMOR OF ANAL CANAL	0.00392157	0.14712220927206404
COMMON VARIABLE IMMUNODEFICIENCY	0.00392157	0.14712220927206404
FAMILIAL PANCREATIC CARCINOMA	0.00392157	0.14712220927206404
CARCINOID SYNDROME	0.00392157	0.14712220927206404
MYH9-RELATED DISEASE	0.00392157	0.14712220927206404
ILEAL NEUROENDOCRINE TUMOR	0.00392157	0.14712220927206404
JEJUNAL NEUROENDOCRINE TUMOR	0.00392157	0.14712220927206404
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.00392157	0.14712220927206404
DUODENAL NEUROENDOCRINE TUMOR	0.00392157	0.14712220927206404
NEUROENDOCRINE TUMOR OF THE RECTUM	0.00392157	0.14712220927206404
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.00392157	0.14712220927206404
NEONATAL LUPUS ERYTHEMATOSUS	0.00392157	0.14712220927206404
GRAFT VERSUS HOST DISEASE	0.00392157	0.14712220927206404
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.00392157	0.14712220927206404
NEUROENDOCRINE TUMOR OF STOMACH	0.00392157	0.14712220927206404
AUTOIMMUNE HEPATITIS	0.00392157	0.14712220927206404
SEVERE CONGENITAL HYPOCHROMIC ANEMIA WITH RINGED SIDEROBLASTS	0.00392157	0.14712220927206404
NEPHROPATHY, PROGRESSIVE TUBULOINTERSTITIAL, WITH CHOLESTATIC LIVERDISEASE	0.00392157	0.14712220927206404
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.00392157	0.14712220927206404
REYNOLDS SYNDROME	0.00392157	0.14712220927206404
ALPHA-1-ANTITRYPSIN DEFICIENCY; A1ATD	0.00392157	0.14712220927206404
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 1	0.00392157	0.14712220927206404
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 3	0.00392157	0.14712220927206404
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 2	0.00392157	0.14712220927206404
INTERSTITIAL NEPHRITIS, KARYOMEGALIC	0.00392157	0.14712220927206404
MCCUNE-ALBRIGHT SYNDROME	0.00392157	0.14712220927206404
HEMOCHROMATOSIS, TYPE 1	0.00392157	0.14712220927206404
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2	0.00392157	0.14712220927206404
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.00392157	0.14712220927206404
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.00392157	0.14712220927206404
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.00392157	0.14712220927206404
PEDIATRIC-ONSET GRAVES DISEASE	0.00392157	0.14712220927206404
DK1-CDG	0.00392157	0.14712220927206404
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.00392157	0.14712220927206404
WILSON DISEASE	0.00392157	0.14712220927206404
RETINITIS PIGMENTOSA 71; RP71	0.00392157	0.14712220927206404
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.00392157	0.14712220927206404
BECKER MUSCULAR DYSTROPHY	0.00392157	0.14712220927206404
BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS	0.00392157	0.14712220927206404
HEMOCHROMATOSIS, TYPE 2B	0.00392157	0.14712220927206404
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.00392157	0.14712220927206404
HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1	0.00392157	0.14712220927206404
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.00392157	0.14712220927206404
%210500 BILIARY ATRESIA, EXTRAHEPATIC; EHBA	0.00392157	0.14712220927206404
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.00392157	0.14712220927206404
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1	0.00392157	0.14712220927206404
MEVALONIC ACIDURIA; MEVA	0.00392157	0.14712220927206404
GLYCINE N-METHYLTRANSFERASE DEFICIENCY	0.00392157	0.14712220927206404
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.00392157	0.14712220927206404
HEMOCHROMATOSIS, TYPE 3; HFE3	0.00392157	0.14712220927206404
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.00392157	0.14712220927206404
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4	0.00392157	0.14712220927206404
ALSTROM SYNDROME; ALMS	0.00392157	0.14712220927206404
XFE PROGEROID SYNDROME; XFEPS	0.00392157	0.14712220927206404
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3; PFIC3	0.00392157	0.14712220927206404
CHYLOMICRON RETENTION DISEASE	0.00392157	0.14712220927206404
DISORDER OF BILE ACID SYNTHESIS	0.00392157	0.14712220927206404
HEMOCHROMATOSIS TYPE 2	0.00392157	0.14712220927206404
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00392157	0.14712220927206404
HARDIKAR SYNDROME	0.00392157	0.14712220927206404
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 15; MDDGC15	0.00392157	0.14712220927206404
ANEMIA, SIDEROBLASTIC, 3, PYRIDOXINE-REFRACTORY; SIDBA3	0.00392157	0.14712220927206404
TOXIC EPIDERMAL NECROLYSIS	0.00392157	0.14712220927206404
X-LINKED SIDEROBLASTIC ANEMIA	0.00392157	0.14712220927206404
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.00392157	0.14712220927206404
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.00392157	0.14712220927206404
SCLEROSING CHOLANGITIS, NEONATAL	0.00392157	0.14712220927206404
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.00392157	0.14712220927206404
MOSAIC MONOSOMY X	0.00392157	0.14712220927206404
BARDET-BIEDL SYNDROME 21; BBS21	0.00392157	0.14712220927206404
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.00392157	0.14712220927206404
NEUTRAL LIPID STORAGE MYOPATHY	0.00392157	0.14712220927206404
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.00392157	0.14712220927206404
MONOSOMY X	0.00392157	0.14712220927206404
CHRONIC GRAFT VERSUS HOST DISEASE	0.00392157	0.14712220927206404
RENAL CYSTS AND DIABETES SYNDROME; RCAD	0.00392157	0.14712220927206404
LYSINURIC PROTEIN INTOLERANCE	0.00392157	0.14712220927206404
TURNER SYNDROME	0.00392157	0.14712220927206404
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00378788	0.14210667514731748
SCHIZOPHRENIA 4	0.00378788	0.14210667514731748
PYGMY	0.00378788	0.14210667514731748
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00378788	0.14210667514731748
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.00378788	0.14210667514731748
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00378788	0.14210667514731748
REVESZ SYNDROME	0.00378788	0.14210667514731748
TRISOMY 18-LIKE SYNDROME	0.00378788	0.14210667514731748
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00378788	0.14210667514731748
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00378788	0.14210667514731748
DERMATOLEUKODYSTROPHY	0.00378788	0.14210667514731748
CONE-ROD DYSTROPHY 1; CORD1	0.00378788	0.14210667514731748
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00378788	0.14210667514731748
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.00378788	0.14210667514731748
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00378788	0.14210667514731748
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00378788	0.14210667514731748
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.00378788	0.14210667514731748
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.00378788	0.14210667514731748
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.00378788	0.14210667514731748
MACROCYTOSIS, FAMILIAL	0.00378788	0.14210667514731748
LACTOSE INTOLERANCE, ADULT TYPE	0.00378788	0.14210667514731748
ONCOCYTOMA	0.00378788	0.14210667514731748
GONADOBLASTOMA	0.00378788	0.14210667514731748
DELETED IN AZOOSPERMIA	0.00378788	0.14210667514731748
XM SYSTEM	0.00378788	0.14210667514731748
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00378788	0.14210667514731748
MACULAR DYSTROPHY, CORNEAL, 1	0.00378788	0.14210667514731748
PSEUDOURIDINURIA AND MENTAL DEFECT	0.00378788	0.14210667514731748
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00378788	0.14210667514731748
REFSUM DISEASE	0.00378788	0.14210667514731748
CEPHALIN LIPIDOSIS	0.00378788	0.14210667514731748
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00378788	0.14210667514731748
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00378788	0.14210667514731748
PREMATURE CENTROMERE DIVISION; PCD	0.00378788	0.14210667514731748
CARDIAC LIPIDOSIS, FAMILIAL	0.00378788	0.14210667514731748
SPERMATOGENIC FAILURE 1; SPGF1	0.00378788	0.14210667514731748
OCULORENOCEREBELLAR SYNDROME	0.00378788	0.14210667514731748
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.00378788	0.14210667514731748
257960 OCULOTRICHODYSPLASIA; OTD	0.00378788	0.14210667514731748
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00378788	0.14210667514731748
LARSEN-LIKE SYNDROME	0.00378788	0.14210667514731748
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00378788	0.14210667514731748
%608572 BURN-MCKEOWN SYNDROME	0.00378788	0.14210667514731748
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00378788	0.14210667514731748
CEREBELLOPARENCHYMAL DISORDER V	0.00378788	0.14210667514731748
OSTEOGENIC SARCOMA	0.00378788	0.14210667514731748
LARON SYNDROME	0.00378788	0.14210667514731748
PITUITARY DWARFISM IV	0.00378788	0.14210667514731748
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00378788	0.14210667514731748
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.00378788	0.14210667514731748
DERMATITIS, ATOPIC	0.00378788	0.14210667514731748
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00378788	0.14210667514731748
PROGESTERONE RESISTANCE	0.00378788	0.14210667514731748
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00378788	0.14210667514731748
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00378788	0.14210667514731748
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.00378788	0.14210667514731748
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00378788	0.14210667514731748
CITRULLINE TRANSPORT DEFECT	0.00378788	0.14210667514731748
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.00378788	0.14210667514731748
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.00378788	0.14210667514731748
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.00378788	0.14210667514731748
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00378788	0.14210667514731748
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.00378788	0.14210667514731748
EHLERS-DANLOS SYNDROME, TYPE VI	0.00378788	0.14210667514731748
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00378788	0.14210667514731748
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00378788	0.14210667514731748
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00378788	0.14210667514731748
46,XX GONADAL DYSGENESIS	0.00378788	0.14210667514731748
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00378788	0.14210667514731748
TESTICULAR GERM CELL TUMOR; TGCT	0.00378788	0.14210667514731748
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00378788	0.14210667514731748
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00378788	0.14210667514731748
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.00378788	0.14210667514731748
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00378788	0.14210667514731748
MAGNESIUM, ELEVATED RED CELL	0.00378788	0.14210667514731748
ALAND ISLAND EYE DISEASE	0.00378788	0.14210667514731748
LYMPHOKINE DEFICIENCY	0.00378788	0.14210667514731748
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00378788	0.14210667514731748
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00378788	0.14210667514731748
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00378788	0.14210667514731748
MYELOPEROXIDASE DEFICIENCY	0.00378788	0.14210667514731748
HEREDITARY HYPERFERRITINEMIA-CATARACT SYNDROME	0.00378788	0.14210667514731748
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00378788	0.14210667514731748
PENDRED SYNDROME	0.00378788	0.14210667514731748
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00378788	0.14210667514731748
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00378788	0.14210667514731748
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00378788	0.14210667514731748
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00378788	0.14210667514731748
NEPHROSIALIDOSIS	0.00378788	0.14210667514731748
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00378788	0.14210667514731748
XANTHINURIA, TYPE I	0.00378788	0.14210667514731748
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.00378788	0.14210667514731748
T-SUBSTANCE ANOMALY	0.00378788	0.14210667514731748
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00378788	0.14210667514731748
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.00378788	0.14210667514731748
CUTIS LAXA	0.00378788	0.14210667514731748
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00378788	0.14210667514731748
LIPASE DEFICIENCY, COMBINED	0.00378788	0.14210667514731748
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.00378788	0.14210667514731748
ACETYLATION, SLOW	0.00378788	0.14210667514731748
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00378788	0.14210667514731748
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.00378788	0.14210667514731748
ICHTHYOSIS, X-LINKED	0.00378788	0.14210667514731748
GLUTATHIONURIA	0.00378788	0.14210667514731748
LUTHERAN SUPPRESSOR, X-LINKED	0.00378788	0.14210667514731748
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00378788	0.14210667514731748
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00378788	0.14210667514731748
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00378788	0.14210667514731748
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.00378788	0.14210667514731748
FETAL IODINE DEFICIENCY DISORDER	0.00378788	0.14210667514731748
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00378788	0.14210667514731748
PREMATURE OVARIAN FAILURE 1	0.00378788	0.14210667514731748
ETHANOLAMINOSIS	0.00378788	0.14210667514731748
PROPERDIN DEFICIENCY, X-LINKED	0.00378788	0.14210667514731748
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00378788	0.14210667514731748
SERTOLI CELL-ONLY SYNDROME	0.00378788	0.14210667514731748
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00378788	0.14210667514731748
FINGERPRINT BODY MYOPATHY	0.00378788	0.14210667514731748
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00378788	0.14210667514731748
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.00378788	0.14210667514731748
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00378788	0.14210667514731748
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00378788	0.14210667514731748
CALVARIAL HYPEROSTOSIS	0.00378788	0.14210667514731748
AREDYLD	0.00378788	0.14210667514731748
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.00378788	0.14210667514731748
HOOFT DISEASE	0.00378788	0.14210667514731748
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.00378788	0.14210667514731748
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00378788	0.14210667514731748
HYPOASCORBEMIA	0.00378788	0.14210667514731748
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00378788	0.14210667514731748
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.00378788	0.14210667514731748
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.00378788	0.14210667514731748
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00378788	0.14210667514731748
NEUTROPHIL ACTIN DYSFUNCTION	0.00378788	0.14210667514731748
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.00378788	0.14210667514731748
OSTEOMESOPYKNOSIS	0.00378788	0.14210667514731748
CHOROIDAL OSTEOMA, BILATERAL	0.00378788	0.14210667514731748
CATECHOL-O-METHYLTRANSFERASE	0.00378788	0.14210667514731748
PACMAN DYSPLASIA	0.00378788	0.14210667514731748
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.00378788	0.14210667514731748
NORMOKALEMIC PERIODIC PARALYSIS	0.00378788	0.14210667514731748
FLOOD FACTOR DEFICIENCY	0.00378788	0.14210667514731748
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00378788	0.14210667514731748
OVARIAN CANCER	0.00378788	0.14210667514731748
CONGENITAL ADRENAL HYPERPLASIA	0.00378788	0.14210667514731748
CARBOXYLESTERASE 1	0.00378788	0.14210667514731748
POLYCYSTIC OVARY SYNDROME 1	0.00378788	0.14210667514731748
ALKAPTONURIA	0.00378788	0.14210667514731748
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00378788	0.14210667514731748
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.00378788	0.14210667514731748
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.00378788	0.14210667514731748
BLOOD GROUP, DUFFY SYSTEM; FY	0.00378788	0.14210667514731748
PARAOXONASE 1	0.00378788	0.14210667514731748
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00378788	0.14210667514731748
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00378788	0.14210667514731748
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.00378788	0.14210667514731748
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00378788	0.14210667514731748
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00378788	0.14210667514731748
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.00378788	0.14210667514731748
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.00378788	0.14210667514731748
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00378788	0.14210667514731748
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00378788	0.14210667514731748
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00378788	0.14210667514731748
WHITE SPONGE NEVUS OF CANNON	0.00378788	0.14210667514731748
URATE-BINDING GLOBULIN, DECREASE IN	0.00378788	0.14210667514731748
ZINC, ELEVATED PLASMA	0.00378788	0.14210667514731748
COUMARIN RESISTANCE	0.00378788	0.14210667514731748
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00378788	0.14210667514731748
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00378788	0.14210667514731748
MACULAR CORNEAL DYSTROPHY	0.00378788	0.14210667514731748
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00378788	0.14210667514731748
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.00378788	0.14210667514731748
PERRY SYNDROME	0.00378788	0.14210667514731748
SPINAL ARACHNOIDITIS	0.00378788	0.14210667514731748
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.00378788	0.14210667514731748
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.00378788	0.14210667514731748
HEINZ BODY ANEMIAS	0.00378788	0.14210667514731748
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00378788	0.14210667514731748
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00378788	0.14210667514731748
HYPERPROGLUCAGONEMIA	0.00378788	0.14210667514731748
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00378788	0.14210667514731748
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00378788	0.14210667514731748
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00378788	0.14210667514731748
KERATOSIS, FAMILIAL ACTINIC	0.00378788	0.14210667514731748
GLUTATHIONE REDUCTASE	0.00378788	0.14210667514731748
APOLIPOPROTEIN(A)	0.00378788	0.14210667514731748
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00378788	0.14210667514731748
BARTTER SYNDROME	0.00378788	0.14210667514731748
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00378788	0.14210667514731748
MYOPATHY, SPHEROID BODY	0.00378788	0.14210667514731748
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.00378788	0.14210667514731748
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00378788	0.14210667514731748
CUTANEOUS COLLAGENOUS VASCULOPATHY	0.00378788	0.14210667514731748
GLOMUVENOUS MALFORMATIONS	0.00378788	0.14210667514731748
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00378788	0.14210667514731748
OSTEOGENESIS IMPERFECTA, TYPE V	0.00378788	0.14210667514731748
BEETURIA	0.00378788	0.14210667514731748
KAPOSIFORM LYMPHANGIOMATOSIS	0.00373134	0.13998551201310275
CONGENITAL ENTEROVIRUS INFECTION	0.00373134	0.13998551201310275
KUFOR-RAKEB SYNDROME	0.00373134	0.13998551201310275
BACTERIAL SUSCEPTIBILITY DUE TO TLR SIGNALING PATHWAY DEFICIENCY	0.00373134	0.13998551201310275
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	0.00373134	0.13998551201310275
MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASES DUE TO PARTIAL IRF8 DEFICIENCY	0.00373134	0.13998551201310275
MANTLE CELL LYMPHOMA	0.00373134	0.13998551201310275
MALT LYMPHOMA	0.00373134	0.13998551201310275
RHEUMATIC FEVER-RELATED ANTIGENRHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED	0.00373134	0.13998551201310275
ANTISYNTHETASE SYNDROME	0.00373134	0.13998551201310275
HYPOHIDROSIS WITH ABNORMAL PALMAR DERMAL RIDGES	0.00373134	0.13998551201310275
WOUND BOTULISM	0.00373134	0.13998551201310275
SEVERE COMBINED IMMUNODEFICIENCY	0.00373134	0.13998551201310275
HEREDITARY SPHEROCYTOSIS	0.00373134	0.13998551201310275
POLYEMBRYOMA	0.00373134	0.13998551201310275
JUVENILE IDIOPATHIC ARTHRITIS	0.00373134	0.13998551201310275
DYSTONIA 12; DYT12	0.00373134	0.13998551201310275
RHABDOMYOLYSIS, ACUTE RECURRENT	0.00373134	0.13998551201310275
DERMATOMYOSITIS	0.00373134	0.13998551201310275
KLATSKIN TUMOR	0.00373134	0.13998551201310275
ACUTE PROMYELOCYTIC LEUKEMIA	0.00373134	0.13998551201310275
CUTANEOUS SMALL VESSEL VASCULITIS	0.00373134	0.13998551201310275
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.00373134	0.13998551201310275
AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC	0.00373134	0.13998551201310275
RETICULAR DYSGENESIS	0.00373134	0.13998551201310275
MYELOFIBROSISMYELOFIBROSIS WITH MYELOID METAPLASIA, INCLUDED	0.00373134	0.13998551201310275
SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS	0.00373134	0.13998551201310275
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 4; FCAS4	0.00373134	0.13998551201310275
REFRACTORY ANEMIA WITH EXCESS BLASTS	0.00373134	0.13998551201310275
SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA	0.00373134	0.13998551201310275
NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA	0.00373134	0.13998551201310275
CYCLIC NEUTROPENIA	0.00373134	0.13998551201310275
WELLS SYNDROME	0.00373134	0.13998551201310275
AUTOSOMAL AGAMMAGLOBULINEMIA	0.00373134	0.13998551201310275
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.00373134	0.13998551201310275
FOCAL MYOSITIS	0.00373134	0.13998551201310275
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.00373134	0.13998551201310275
AUTOSOMAL DOMINANT SEVERE CONGENITAL NEUTROPENIA	0.00373134	0.13998551201310275
TETANUS	0.00373134	0.13998551201310275
CONGENITAL FIBRINOGEN DEFICIENCY	0.00373134	0.13998551201310275
NODULAR NON-SUPPURATIVE PANNICULITIS	0.00373134	0.13998551201310275
TUBERCULOSIS	0.00373134	0.13998551201310275
PANCREATITIS, HEREDITARY	0.00373134	0.13998551201310275
CHRONIC MYELOID LEUKEMIA	0.00373134	0.13998551201310275
MELKERSSON-ROSENTHAL SYNDROME	0.00373134	0.13998551201310275
CRYOGLOBULINEMIC VASCULITIS	0.00373134	0.13998551201310275
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.00373134	0.13998551201310275
RAGWEED SENSITIVITY	0.00373134	0.13998551201310275
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.00373134	0.13998551201310275
HEREDITARY ELLIPTOCYTOSIS	0.00373134	0.13998551201310275
ACUTE MONOBLASTIC LEUKEMIA	0.00373134	0.13998551201310275
X-LINKED AGAMMAGLOBULINEMIA	0.00373134	0.13998551201310275
WISKOTT-ALDRICH SYNDROME	0.00373134	0.13998551201310275
DUBIN-JOHNSON SYNDROME	0.00373134	0.13998551201310275
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.00373134	0.13998551201310275
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.00373134	0.13998551201310275
LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2	0.00373134	0.13998551201310275
T-CELL LYMPHOMA, SUBCUTANEOUS PANNICULITIS-LIKE; SPTCL	0.00373134	0.13998551201310275
GAMMA-HEAVY CHAIN DISEASE	0.00373134	0.13998551201310275
PYOGENIC ARTHRITIS-PYODERMA GANGRENOSUM-ACNE SYNDROME	0.00373134	0.13998551201310275
NEUROPATHY, PAINFUL	0.00373134	0.13998551201310275
NEUROPATHY, HEREDITARY THERMOSENSITIVE	0.00373134	0.13998551201310275
MULTICENTRIC RETICULOHISTIOCYTOSIS	0.00373134	0.13998551201310275
OMENN SYNDROME	0.00373134	0.13998551201310275
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5	0.00373134	0.13998551201310275
CIRRHOSIS, FAMILIAL	0.00373134	0.13998551201310275
CHOLANGIOCARCINOMA	0.00373134	0.13998551201310275
CAFFEY DISEASE	0.00373134	0.13998551201310275
AREGENERATIVE ANEMIA	0.00373134	0.13998551201310275
CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.00373134	0.13998551201310275
OSTEOSARCOMA	0.00373134	0.13998551201310275
ISOLATED AGAMMAGLOBULINEMIA	0.00373134	0.13998551201310275
NEPHROBLASTOMA	0.00373134	0.13998551201310275
MIXED-TYPE AUTOIMMUNE HEMOLYTIC ANEMIA	0.00373134	0.13998551201310275
FOLLICULAR LYMPHOMA	0.00373134	0.13998551201310275
ALPHA-HEAVY CHAIN DISEASE	0.00373134	0.13998551201310275
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.00373134	0.13998551201310275
DRUG-INDUCED LUPUS ERYTHEMATOSUS	0.00373134	0.13998551201310275
ADULT IDIOPATHIC NEUTROPENIA	0.00373134	0.13998551201310275
POLYMYOSITIS	0.00373134	0.13998551201310275
ATYPICAL MYCOBACTERIOSIS, FAMILIAL	0.00373134	0.13998551201310275
WOLMAN DISEASE	0.00373134	0.13998551201310275
AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS	0.00373134	0.13998551201310275
CRYPTOGENIC ORGANIZING PNEUMONIA	0.00373134	0.13998551201310275
PYOMYOSITIS	0.00373134	0.13998551201310275
CAFFEY DISEASE	0.00373134	0.13998551201310275
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.00373134	0.13998551201310275
ROTOR SYNDROME	0.00373134	0.13998551201310275
CHRONIC GRANULOMATOUS DISEASE	0.00373134	0.13998551201310275
ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE	0.00373134	0.13998551201310275
MELIOIDOSIS	0.00373134	0.13998551201310275
CINCA SYNDROME; CINCA	0.00373134	0.13998551201310275
MICROSCOPIC POLYANGIITIS	0.00373134	0.13998551201310275
REYNOLDS SYNDROME	0.00373134	0.13998551201310275
IDIOPATHIC ACUTE EOSINOPHILIC PNEUMONIA	0.00373134	0.13998551201310275
SCHNITZLER SYNDROME	0.00373134	0.13998551201310275
MU-HEAVY CHAIN DISEASE	0.00373134	0.13998551201310275
CYSTINOSIS	0.00373134	0.13998551201310275
ERDHEIM-CHESTER DISEASE	0.00373134	0.13998551201310275
JUVENILE DERMATOMYOSITIS	0.00373134	0.13998551201310275
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.00373134	0.13998551201310275
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.00373134	0.13998551201310275
STIFF-PERSON SYNDROME; SPS	0.00373134	0.13998551201310275
PULMONARY BLASTOMA	0.00373134	0.13998551201310275
FEVER, FAMILIAL LIFELONG PERSISTENT	0.00373134	0.13998551201310275
DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE	0.00373134	0.13998551201310275
PYODERMA GANGRENOSUM	0.00373134	0.13998551201310275
RECURRENT RESPIRATORY PAPILLOMATOSIS	0.00373134	0.13998551201310275
MUCKLE-WELLS SYNDROME	0.00373134	0.13998551201310275
SARCOIDOSIS	0.00373134	0.13998551201310275
GLYCOGEN STORAGE DISEASE II	0.00373134	0.13998551201310275
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO CD3DELTA/CD3EPSILON/CD3ZETA	0.00373134	0.13998551201310275
HALOTHANE HEPATITIS	0.00373134	0.13998551201310275
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.00373134	0.13998551201310275
MACROPHAGIC MYOFASCIITIS	0.00373134	0.13998551201310275
IMMUNODEFICIENCY 32B; IMD32B	0.00373134	0.13998551201310275
PSORIASIS 14, PUSTULAR	0.00373134	0.13998551201310275
PROGRESSIVE NODULAR HISTIOCYTOSIS	0.00373134	0.13998551201310275
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.00373134	0.13998551201310275
HEREDITARY CENTRAL DIABETES INSIPIDUS	0.00373134	0.13998551201310275
PSEUDODIASTROPHIC DYSPLASIA	0.00373134	0.13998551201310275
MALAKOPLAKIA	0.00373134	0.13998551201310275
REACTIVE ARTHRITIS	0.00373134	0.13998551201310275
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.00373134	0.13998551201310275
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO IL-7RALPHA DEFICIENCY	0.00373134	0.13998551201310275
CONGENITAL PRIMARY MEGAURETER	0.00373134	0.13998551201310275
FAMILIAL ATRIAL MYXOMA	0.00373134	0.13998551201310275
LATE-ONSET FAMILIAL HYPOALDOSTERONISM	0.00373134	0.13998551201310275
CHRONIC NONBACTERIAL OSTEOMYELITIS/CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.00373134	0.13998551201310275
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.00373134	0.13998551201310275
IDIOPATHIC BRONCHIECTASIS	0.00373134	0.13998551201310275
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.020311956543392476
SECONDARY SYRINGOMYELIA	0.000541419	0.020311956543392476
FOUNTAIN SYNDROME	0.000541419	0.020311956543392476
HADDAD SYNDROME	0.000541419	0.020311956543392476
RENPENNING SYNDROME	0.000541419	0.020311956543392476
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.020311956543392476
QAZI-MARKOUIZOS SYNDROME	0.000541419	0.020311956543392476
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000541419	0.020311956543392476
11P15.4 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
RAMON SYNDROME	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.000541419	0.020311956543392476
DERMOTRICHIC SYNDROME	0.000541419	0.020311956543392476
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.000541419	0.020311956543392476
DISTAL MONOSOMY 10Q	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.000541419	0.020311956543392476
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.000541419	0.020311956543392476
FG SYNDROME TYPE 1	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.000541419	0.020311956543392476
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY, WOLFF TYPE	0.000541419	0.020311956543392476
49,XXXXY SYNDROME	0.000541419	0.020311956543392476
GM2 GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.020311956543392476
48,XXXY SYNDROME	0.000541419	0.020311956543392476
SMITH-FINEMAN-MYERS SYNDROME	0.000541419	0.020311956543392476
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.020311956543392476
15Q24 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.000541419	0.020311956543392476
PARTINGTON SYNDROME	0.000541419	0.020311956543392476
EMANUEL SYNDROME	0.000541419	0.020311956543392476
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.000541419	0.020311956543392476
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.000541419	0.020311956543392476
20P13 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
KOOLEN-DE VRIES SYNDROME	0.000541419	0.020311956543392476
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.000541419	0.020311956543392476
RECOMBINANT 8 SYNDROME	0.000541419	0.020311956543392476
RUVALCABA SYNDROME	0.000541419	0.020311956543392476
NON-DISTAL MONOSOMY 20Q	0.000541419	0.020311956543392476
8P INVERTED DUPLICATION/DELETION SYNDROME	0.000541419	0.020311956543392476
7Q11.23 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
DISTAL MONOSOMY 19P13.3	0.000541419	0.020311956543392476
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000541419	0.020311956543392476
THANATOPHORIC DYSPLASIA TYPE 2	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.000541419	0.020311956543392476
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA TYPE 13	0.000541419	0.020311956543392476
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.000541419	0.020311956543392476
ADRENOMYODYSTROPHY	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.020311956543392476
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.000541419	0.020311956543392476
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.000541419	0.020311956543392476
ADAMS-OLIVER SYNDROME	0.000541419	0.020311956543392476
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.020311956543392476
FRAGILE X SYNDROME	0.000541419	0.020311956543392476
CEREBROTENDINOUS XANTHOMATOSIS	0.000541419	0.020311956543392476
HEREDITARY HYPEREKPLEXIA	0.000541419	0.020311956543392476
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.000541419	0.020311956543392476
ZELLWEGER SYNDROME	0.000541419	0.020311956543392476
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.000541419	0.020311956543392476
WIEDEMANN-STEINER SYNDROME	0.000541419	0.020311956543392476
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.000541419	0.020311956543392476
ASPARTYLGLUCOSAMINURIA	0.000541419	0.020311956543392476
ATYPICAL RETT SYNDROME	0.000541419	0.020311956543392476
SEVERE CANAVAN DISEASE	0.000541419	0.020311956543392476
BOHRING-OPITZ SYNDROME	0.000541419	0.020311956543392476
HEMIDYSTONIA-HEMIATROPHY SYNDROME	0.000541419	0.020311956543392476
PFEIFFER SYNDROME TYPE 2	0.000541419	0.020311956543392476
PFEIFFER SYNDROME TYPE 3	0.000541419	0.020311956543392476
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.000541419	0.020311956543392476
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.000541419	0.020311956543392476
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.000541419	0.020311956543392476
MAN1B1-CDG	0.000541419	0.020311956543392476
PRADER-WILLI-LIKE SYNDROME	0.000541419	0.020311956543392476
X-LINKED CENTRONUCLEAR MYOPATHY	0.000541419	0.020311956543392476
CENTRONUCLEAR MYOPATHY	0.000541419	0.020311956543392476
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
CONGENITAL MYASTHENIC SYNDROME	0.000541419	0.020311956543392476
MYASTHENIA GRAVIS	0.000541419	0.020311956543392476
MUSCLE-EYE-BRAIN DISEASE	0.000541419	0.020311956543392476
MULTIPLE SULFATASE DEFICIENCY	0.000541419	0.020311956543392476
MUCOPOLYSACCHARIDOSIS TYPE 3	0.000541419	0.020311956543392476
MUCOPOLYSACCHARIDOSIS TYPE 2	0.000541419	0.020311956543392476
ALEXANDER DISEASE	0.000541419	0.020311956543392476
MEND SYNDROME	0.000541419	0.020311956543392476
MICROPHTHALMIA, LENZ TYPE	0.000541419	0.020311956543392476
22Q11.2 DELETION SYNDROME	0.000541419	0.020311956543392476
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
ADNP SYNDROME	0.000541419	0.020311956543392476
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.000541419	0.020311956543392476
9Q21.13 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
LIPOID PROTEINOSIS	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.000541419	0.020311956543392476
17Q24.2 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.000541419	0.020311956543392476
HEREDITARY METHEMOGLOBINEMIA	0.000541419	0.020311956543392476
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.020311956543392476
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.000541419	0.020311956543392476
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.000541419	0.020311956543392476
STT3A-CDG	0.000541419	0.020311956543392476
STT3B-CDG	0.000541419	0.020311956543392476
SSR4-CDG	0.000541419	0.020311956543392476
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.000541419	0.020311956543392476
PROTEUS SYNDROME	0.000541419	0.020311956543392476
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.000541419	0.020311956543392476
ANGELMAN SYNDROME	0.000541419	0.020311956543392476
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.020311956543392476
RAPID-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.020311956543392476
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
ATYPICAL JUVENILE PARKINSONISM	0.000541419	0.020311956543392476
PRIMARY CUTIS VERTICIS GYRATA	0.000541419	0.020311956543392476
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.000541419	0.020311956543392476
ONDINE SYNDROME	0.000541419	0.020311956543392476
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.020311956543392476
LEBER CONGENITAL AMAUROSIS	0.000541419	0.020311956543392476
NEVUS COMEDONICUS SYNDROME	0.000541419	0.020311956543392476
NIEMANN-PICK DISEASE TYPE C	0.000541419	0.020311956543392476
ALSTRÖM SYNDROME	0.000541419	0.020311956543392476
NETHERTON SYNDROME	0.000541419	0.020311956543392476
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.000541419	0.020311956543392476
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.020311956543392476
FAMILIAL MULTIPLE NEVI FLAMMEI	0.000541419	0.020311956543392476
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.000541419	0.020311956543392476
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
TEMPLE-BARAITSER SYNDROME	0.000541419	0.020311956543392476
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.000541419	0.020311956543392476
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.000541419	0.020311956543392476
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.000541419	0.020311956543392476
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
PHACE SYNDROME	0.000541419	0.020311956543392476
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.020311956543392476
INCONTINENTIA PIGMENTI	0.000541419	0.020311956543392476
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.020311956543392476
KEPPEN-LUBINSKY SYNDROME	0.000541419	0.020311956543392476
LATHOSTEROLOSIS	0.000541419	0.020311956543392476
ADENYLOSUCCINATE LYASE DEFICIENCY	0.000541419	0.020311956543392476
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.000541419	0.020311956543392476
HYPOPHOSPHATASIA	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.000541419	0.020311956543392476
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.000541419	0.020311956543392476
11Q22.2Q22.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
PGM3-CDG	0.000541419	0.020311956543392476
CONO-SPONDYLAR DYSPLASIA	0.000541419	0.020311956543392476
JOUBERT SYNDROME	0.000541419	0.020311956543392476
XQ25 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
WHIM SYNDROME	0.000541419	0.020311956543392476
METACHROMATIC LEUKODYSTROPHY	0.000541419	0.020311956543392476
MAPLE SYRUP URINE DISEASE	0.000541419	0.020311956543392476
8Q24.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.000541419	0.020311956543392476
LEIGH SYNDROME	0.000541419	0.020311956543392476
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.020311956543392476
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.000541419	0.020311956543392476
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.000541419	0.020311956543392476
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.000541419	0.020311956543392476
16P13.2 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
9Q33.3Q34.11 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.000541419	0.020311956543392476
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.000541419	0.020311956543392476
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.000541419	0.020311956543392476
MONOSOMY 22Q13.3	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.000541419	0.020311956543392476
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
DYSTONIA-APHONIA SYNDROME	0.000541419	0.020311956543392476
GYRATE ATROPHY OF CHOROID AND RETINA	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.000541419	0.020311956543392476
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.000541419	0.020311956543392476
KALLMANN SYNDROME	0.000541419	0.020311956543392476
HYPERPROLINEMIA TYPE 1	0.000541419	0.020311956543392476
6Q TERMINAL DELETION SYNDROME	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.000541419	0.020311956543392476
HEREDITARY FOLATE MALABSORPTION	0.000541419	0.020311956543392476
DISTAL TRISOMY 17Q	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.020311956543392476
MEHMO SYNDROME	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.000541419	0.020311956543392476
FETAL GAUCHER DISEASE	0.000541419	0.020311956543392476
KEUTEL SYNDROME	0.000541419	0.020311956543392476
GENITOPATELLAR SYNDROME	0.000541419	0.020311956543392476
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.000541419	0.020311956543392476
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
TAY-SACHS DISEASE	0.000541419	0.020311956543392476
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392476
WILSON-TURNER SYNDROME	0.000541419	0.020311956543392476
CAMOS SYNDROME	0.000541419	0.020311956543392476
FREE SIALIC ACID STORAGE DISEASE	0.000541419	0.020311956543392476
WOLFRAM SYNDROME	0.000541419	0.020311956543392476
WORSTER-DROUGHT SYNDROME	0.000541419	0.020311956543392476
ZIMMERMANN-LABAND SYNDROME	0.000541419	0.020311956543392476
CHIME SYNDROME	0.000541419	0.020311956543392476
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.000541419	0.020311956543392476
ISOLATED SPINA BIFIDA	0.000541419	0.020311956543392476
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.020311956543392476
TRISOMY 13	0.000541419	0.020311956543392476
FUCOSIDOSIS	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.000541419	0.020311956543392476
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.020311956543392476
ZLOTOGORA-OGUR SYNDROME	0.000541419	0.020311956543392476
ARGININEMIA	0.000541419	0.020311956543392476
FILIPPI SYNDROME	0.000541419	0.020311956543392476
WALKER-WARBURG SYNDROME	0.000541419	0.020311956543392476
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.000541419	0.020311956543392476
MERCURY POISONING	0.000541419	0.020311956543392476
SIALIDOSIS TYPE 2	0.000541419	0.020311956543392476
DUPLICATION/INVERSION 15Q11	0.000541419	0.020311956543392476
TETRASOMY 18P	0.000541419	0.020311956543392476
TETRASOMY 5P	0.000541419	0.020311956543392476
TETRASOMY 9P	0.000541419	0.020311956543392476
TRIPLE A SYNDROME	0.000541419	0.020311956543392476
DPAGT1-CDG	0.000541419	0.020311956543392476
THYROCEREBRORENAL SYNDROME	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.000541419	0.020311956543392476
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.000541419	0.020311956543392476
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.000541419	0.020311956543392476
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.000541419	0.020311956543392476
TRISOMY X	0.000541419	0.020311956543392476
SMITH-MAGENIS SYNDROME	0.000541419	0.020311956543392476
SMITH-LEMLI-OPITZ SYNDROME	0.000541419	0.020311956543392476
PYRUVATE DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392476
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.020311956543392476
DISTAL MONOSOMY 1Q	0.000541419	0.020311956543392476
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.000541419	0.020311956543392476
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.000541419	0.020311956543392476
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.000541419	0.020311956543392476
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.000541419	0.020311956543392476
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.000541419	0.020311956543392476
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.000541419	0.020311956543392476
ACUTE INTERMITTENT PORPHYRIA	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.000541419	0.020311956543392476
HEREDITARY COPROPORPHYRIA	0.000541419	0.020311956543392476
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392476
CLASSIC PHENYLKETONURIA	0.000541419	0.020311956543392476
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.020311956543392476
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.020311956543392476
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.000541419	0.020311956543392476
EPISODIC ATAXIA TYPE 3	0.000541419	0.020311956543392476
DEND SYNDROME	0.000541419	0.020311956543392476
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.000541419	0.020311956543392476
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.020311956543392476
RUBINSTEIN-TAYBI SYNDROME	0.000541419	0.020311956543392476
RETT SYNDROME	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.000541419	0.020311956543392476
MONOSOMY 9Q22.3	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.000541419	0.020311956543392476
INFANTILE REFSUM DISEASE	0.000541419	0.020311956543392476
20Q11.2 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.000541419	0.020311956543392476
SJÖGREN-LARSSON SYNDROME	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.000541419	0.020311956543392476
SIALIDOSIS TYPE 1	0.000541419	0.020311956543392476
INFANTILE NEUROAXONAL DYSTROPHY	0.000541419	0.020311956543392476
GALACTOSIALIDOSIS	0.000541419	0.020311956543392476
SCLERODERMA	0.000541419	0.020311956543392476
47,XYY SYNDROME	0.000541419	0.020311956543392476
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.000541419	0.020311956543392476
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.000541419	0.020311956543392476
SCHIZENCEPHALY	0.000541419	0.020311956543392476
SANDHOFF DISEASE	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.020311956543392476
GRISCELLI SYNDROME TYPE 1	0.000541419	0.020311956543392476
GM1 GANGLIOSIDOSIS	0.000541419	0.020311956543392476
PORPHYRIA VARIEGATA	0.000541419	0.020311956543392476
ECTODERMAL DYSPLASIA SYNDROME	0.000541419	0.020311956543392476
MOGS-CDG	0.000541419	0.020311956543392476
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.020311956543392476
ALG9-CDG	0.000541419	0.020311956543392476
ALG1-CDG	0.000541419	0.020311956543392476
19P13.13 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
ALG2-CDG	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.000541419	0.020311956543392476
MPDU1-CDG	0.000541419	0.020311956543392476
DPM1-CDG	0.000541419	0.020311956543392476
ALG3-CDG	0.000541419	0.020311956543392476
L-2-HYDROXYGLUTARIC ACIDURIA	0.000541419	0.020311956543392476
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.000541419	0.020311956543392476
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.020311956543392476
SPONTANEOUS PERIODIC HYPOTHERMIA	0.000541419	0.020311956543392476
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.020311956543392476
LISSENCEPHALY 1; LIS1	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000541419	0.020311956543392476
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000541419	0.020311956543392476
KUFOR-RAKEB SYNDROME	0.000541419	0.020311956543392476
PHELAN-MCDERMID SYNDROME	0.000541419	0.020311956543392476
WIEDEMANN-STEINER SYNDROME; WDSTS	0.000541419	0.020311956543392476
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.020311956543392476
BOHRING-OPITZ SYNDROME	0.000541419	0.020311956543392476
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.020311956543392476
ALZHEIMER DISEASE 3; AD	0.000541419	0.020311956543392476
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.000541419	0.020311956543392476
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.000541419	0.020311956543392476
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.000541419	0.020311956543392476
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
MUENKE SYNDROME	0.000541419	0.020311956543392476
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.000541419	0.020311956543392476
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000541419	0.020311956543392476
GRACILE BONE DYSPLASIA; GCLEB	0.000541419	0.020311956543392476
PIERPONT SYNDROME	0.000541419	0.020311956543392476
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.020311956543392476
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.000541419	0.020311956543392476
NIEMANN-PICK DISEASE, TYPE C2	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.000541419	0.020311956543392476
CHROMOSOME 18Q DELETION SYNDROME	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000541419	0.020311956543392476
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.020311956543392476
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.000541419	0.020311956543392476
KLEEFSTRA SYNDROME	0.000541419	0.020311956543392476
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.020311956543392476
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.000541419	0.020311956543392476
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.000541419	0.020311956543392476
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.000541419	0.020311956543392476
SCHINDLER DISEASE, TYPE I	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.000541419	0.020311956543392476
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.000541419	0.020311956543392476
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.000541419	0.020311956543392476
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.000541419	0.020311956543392476
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.000541419	0.020311956543392476
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.000541419	0.020311956543392476
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.000541419	0.020311956543392476
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000541419	0.020311956543392476
KAGAMI-OGATA SYNDROME	0.000541419	0.020311956543392476
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000541419	0.020311956543392476
GAUCHER DISEASE, PERINATAL LETHAL	0.000541419	0.020311956543392476
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392476
PALLISTER-KILLIAN SYNDROME	0.000541419	0.020311956543392476
LEUKOCYTE ADHESION DEFICIENCY	0.000541419	0.020311956543392476
MENKES DISEASE	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.000541419	0.020311956543392476
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.000541419	0.020311956543392476
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.000541419	0.020311956543392476
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 9	0.000541419	0.020311956543392476
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.020311956543392476
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 1	0.000541419	0.020311956543392476
RENPENNING SYNDROME 1; RENS1	0.000541419	0.020311956543392476
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.020311956543392476
INCONTINENTIA PIGMENTI; IP	0.000541419	0.020311956543392476
MUCOPOLYSACCHARIDOSIS, TYPE II	0.000541419	0.020311956543392476
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.000541419	0.020311956543392476
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.020311956543392476
HHHH SYNDROME	0.000541419	0.020311956543392476
PETTIGREW SYNDROME	0.000541419	0.020311956543392476
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000541419	0.020311956543392476
COFFIN-LOWRY SYNDROME; CLS	0.000541419	0.020311956543392476
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.000541419	0.020311956543392476
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.000541419	0.020311956543392476
SHUKLA-VERNON SYNDROME; SHUVER	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000541419	0.020311956543392476
MICROPHTHALMIA, SYNDROMIC 1	0.000541419	0.020311956543392476
OROFACIODIGITAL SYNDROME I; OFD1	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.020311956543392476
CODAS SYNDROME	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.000541419	0.020311956543392476
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.000541419	0.020311956543392476
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.000541419	0.020311956543392476
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.000541419	0.020311956543392476
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000541419	0.020311956543392476
POTOCKI-SHAFFER SYNDROME	0.000541419	0.020311956543392476
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.020311956543392476
GURRIERI SYNDROME	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.000541419	0.020311956543392476
AYME-GRIPP SYNDROME; AYGRP	0.000541419	0.020311956543392476
CHROMOSOME 2Q37 DELETION SYNDROME	0.000541419	0.020311956543392476
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.020311956543392476
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000541419	0.020311956543392476
BAND HETEROTOPIA; BH	0.000541419	0.020311956543392476
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000541419	0.020311956543392476
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.000541419	0.020311956543392476
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.000541419	0.020311956543392476
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000541419	0.020311956543392476
WIEACKER-WOLFF SYNDROME	0.000541419	0.020311956543392476
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.000541419	0.020311956543392476
RETT SYNDROME; RTT	0.000541419	0.020311956543392476
PELIZAEUS-MERZBACHER DISEASE	0.000541419	0.020311956543392476
WAISMAN SYNDROME; WSMN	0.000541419	0.020311956543392476
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.020311956543392476
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.000541419	0.020311956543392476
KOOLEN-DE VRIES SYNDROME; KDVS	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.000541419	0.020311956543392476
COFFIN-SIRIS SYNDROME 3; CSS3	0.000541419	0.020311956543392476
COFFIN-SIRIS SYNDROME 2; CSS2	0.000541419	0.020311956543392476
BARAITSER-WINTER SYNDROME 2; BRWS2	0.000541419	0.020311956543392476
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000541419	0.020311956543392476
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.000541419	0.020311956543392476
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000541419	0.020311956543392476
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.020311956543392476
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.020311956543392476
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.000541419	0.020311956543392476
WARBURG MICRO SYNDROME 3; WARBM3	0.000541419	0.020311956543392476
ADAMS-OLIVER SYNDROME 2; AOS2	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.020311956543392476
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.000541419	0.020311956543392476
MECKEL SYNDROME, TYPE 10; MKS10	0.000541419	0.020311956543392476
PERRAULT SYNDROME 3	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000541419	0.020311956543392476
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.000541419	0.020311956543392476
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.000541419	0.020311956543392476
N-ACETYLASPARTATE DEFICIENCY; NACED	0.000541419	0.020311956543392476
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.000541419	0.020311956543392476
COFFIN-SIRIS SYNDROME 4; CSS4	0.000541419	0.020311956543392476
PONTINE TEGMENTAL CAP DYSPLASIA	0.000541419	0.020311956543392476
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.000541419	0.020311956543392476
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.000541419	0.020311956543392476
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.000541419	0.020311956543392476
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.020311956543392476
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000541419	0.020311956543392476
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000541419	0.020311956543392476
LISSENCEPHALY 5; LIS5	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, 18	0.000541419	0.020311956543392476
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.000541419	0.020311956543392476
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.000541419	0.020311956543392476
SECKEL SYNDROME 7; SCKL7	0.000541419	0.020311956543392476
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.000541419	0.020311956543392476
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.000541419	0.020311956543392476
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.000541419	0.020311956543392476
LISSENCEPHALY 4	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.000541419	0.020311956543392476
LISSENCEPHALY 3; LIS3	0.000541419	0.020311956543392476
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
GLASS SYNDROME	0.000541419	0.020311956543392476
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000541419	0.020311956543392476
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.000541419	0.020311956543392476
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
611961 STEVENSON-CAREY SYNDROME	0.000541419	0.020311956543392476
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.020311956543392476
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.000541419	0.020311956543392476
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.000541419	0.020311956543392476
TEMPLE-BARAITSER SYNDROME; TMBTS	0.000541419	0.020311956543392476
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.000541419	0.020311956543392476
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.000541419	0.020311956543392476
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.000541419	0.020311956543392476
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.000541419	0.020311956543392476
HOLOPROSENCEPHALY 7	0.000541419	0.020311956543392476
CORNELIA DE LANGE SYNDROME 3	0.000541419	0.020311956543392476
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000541419	0.020311956543392476
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.020311956543392476
CHROMOSOME 16P13.3 DELETION SYNDROME	0.000541419	0.020311956543392476
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.000541419	0.020311956543392476
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.000541419	0.020311956543392476
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.000541419	0.020311956543392476
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.000541419	0.020311956543392476
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.000541419	0.020311956543392476
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.000541419	0.020311956543392476
NOONAN SYNDROME 7; NS7	0.000541419	0.020311956543392476
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.000541419	0.020311956543392476
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.000541419	0.020311956543392476
CHROMOSOME 19P13.13 DELETION SYNDROME	0.000541419	0.020311956543392476
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.000541419	0.020311956543392476
RETT SYNDROME, CONGENITAL VARIANT	0.000541419	0.020311956543392476
WITTEVEEN-KOLK SYNDROME	0.000541419	0.020311956543392476
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.000541419	0.020311956543392476
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.000541419	0.020311956543392476
GABA-TRANSAMINASE DEFICIENCY	0.000541419	0.020311956543392476
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.020311956543392476
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000541419	0.020311956543392476
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.000541419	0.020311956543392476
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.000541419	0.020311956543392476
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.000541419	0.020311956543392476
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.000541419	0.020311956543392476
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.000541419	0.020311956543392476
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.000541419	0.020311956543392476
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000541419	0.020311956543392476
CEREBELLOPARENCHYMAL DISORDER II	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.000541419	0.020311956543392476
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.000541419	0.020311956543392476
C SYNDROME	0.000541419	0.020311956543392476
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.020311956543392476
BANGSTAD SYNDROME	0.000541419	0.020311956543392476
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.000541419	0.020311956543392476
SECKEL SYNDROME 1; SCKL1	0.000541419	0.020311956543392476
AUTISM	0.000541419	0.020311956543392476
GRISCELLI SYNDROME, TYPE 1	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000541419	0.020311956543392476
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000541419	0.020311956543392476
ALEXANDER DISEASE	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000541419	0.020311956543392476
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.020311956543392476
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000541419	0.020311956543392476
ACROCALLOSAL SYNDROME; ACLS	0.000541419	0.020311956543392476
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.000541419	0.020311956543392476
DIGEORGE SYNDROME; DGS	0.000541419	0.020311956543392476
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.000541419	0.020311956543392476
COCKAYNE SYNDROME A; CSA	0.000541419	0.020311956543392476
HYPER-BETA-ALANINEMIA	0.000541419	0.020311956543392476
DYSOSTEOSCLEROSIS	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.000541419	0.020311956543392476
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.000541419	0.020311956543392476
MOWAT-WILSON SYNDROME; MOWS	0.000541419	0.020311956543392476
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.000541419	0.020311956543392476
HARTNUP DISORDER	0.000541419	0.020311956543392476
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.000541419	0.020311956543392476
GAUCHER DISEASE, TYPE IIIC	0.000541419	0.020311956543392476
GAUCHER DISEASE, TYPE II	0.000541419	0.020311956543392476
FRYNS SYNDROME; FRNS	0.000541419	0.020311956543392476
FOUNTAIN SYNDROME	0.000541419	0.020311956543392476
FOLATE MALABSORPTION, HEREDITARY	0.000541419	0.020311956543392476
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.020311956543392476
COHEN SYNDROME	0.000541419	0.020311956543392476
DIAMINOPENTANURIA	0.000541419	0.020311956543392476
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.000541419	0.020311956543392476
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.000541419	0.020311956543392476
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.000541419	0.020311956543392476
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.000541419	0.020311956543392476
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.000541419	0.020311956543392476
CROME SYNDROME	0.000541419	0.020311956543392476
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.020311956543392476
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000541419	0.020311956543392476
TEMTAMY SYNDROME; TEMTYS	0.000541419	0.020311956543392476
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.020311956543392476
SUPRABULBAR PARESIS, CONGENITAL	0.000541419	0.020311956543392476
STURGE-WEBER SYNDROME	0.000541419	0.020311956543392476
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.020311956543392476
BRANCHIOOCULOFACIAL SYNDROME	0.000541419	0.020311956543392476
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.020311956543392476
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000541419	0.020311956543392476
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000541419	0.020311956543392476
DARIER-WHITE DISEASE; DAR	0.000541419	0.020311956543392476
CROUZON SYNDROME	0.000541419	0.020311956543392476
CORNELIA DE LANGE SYNDROME 1	0.000541419	0.020311956543392476
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000541419	0.020311956543392476
PAPILLORENAL SYNDROME	0.000541419	0.020311956543392476
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.020311956543392476
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.000541419	0.020311956543392476
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.000541419	0.020311956543392476
ANGELMAN SYNDROME	0.000541419	0.020311956543392476
SMITH-MAGENIS SYNDROME; SMS	0.000541419	0.020311956543392476
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.020311956543392476
ADENYLOSUCCINASE DEFICIENCY	0.000541419	0.020311956543392476
ADAMS-OLIVER SYNDROME 1; AOS1	0.000541419	0.020311956543392476
15Q13.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
ANGELMAN SYNDROME (TYPE 2)	0.000541419	0.020311956543392476
2Q33.1 DELETION SYNDROME	0.000541419	0.020311956543392476
XQ28 (MECP2) DUPLICATION	0.000541419	0.020311956543392476
ANGELMAN SYNDROME (TYPE 1)	0.000541419	0.020311956543392476
PELIZAEUS-MERZBACHER DISEASE	0.000541419	0.020311956543392476
POTOCKI-SHAFFER SYNDROME	0.000541419	0.020311956543392476
1P36 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
EPILEPSY, READING	0.000541419	0.020311956543392476
ZIMMERMANN-LABAND SYNDROME 1	0.000541419	0.020311956543392476
COFFIN-SIRIS SYNDROME 1; CSS1	0.000541419	0.020311956543392476
FLYNN-AIRD SYNDROME	0.000541419	0.020311956543392476
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.000541419	0.020311956543392476
RECOMBINANT CHROMOSOME 8 SYNDROME	0.000541419	0.020311956543392476
PRADER-WILLI SYNDROME; PWS	0.000541419	0.020311956543392476
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.020311956543392476
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000541419	0.020311956543392476
OCULODENTODIGITAL DYSPLASIA; ODDD	0.000541419	0.020311956543392476
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.020311956543392476
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.020311956543392476
NEUROFIBROMATOSIS, TYPE I	0.000541419	0.020311956543392476
HOLOPROSENCEPHALY 2; HPE2	0.000541419	0.020311956543392476
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.020311956543392476
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.000541419	0.020311956543392476
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.020311956543392476
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.020311956543392476
KBG SYNDROME	0.000541419	0.020311956543392476
KABUKI SYNDROME 1	0.000541419	0.020311956543392476
PALLISTER-HALL SYNDROME	0.000541419	0.020311956543392476
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.020311956543392476
HUNTINGTON DISEASE; HD	0.000541419	0.020311956543392476
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.000541419	0.020311956543392476
MYHRE SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.020311956543392476
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.020311956543392476
HYPERLYSINEMIA, TYPE I	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 104; MRX104	0.000541419	0.020311956543392476
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.000541419	0.020311956543392476
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.000541419	0.020311956543392476
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000541419	0.020311956543392476
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.000541419	0.020311956543392476
ATKIN-FLAITZ SYNDROME	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 72	0.000541419	0.020311956543392476
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000541419	0.020311956543392476
LISSENCEPHALY, X-LINKED, 2	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 82	0.000541419	0.020311956543392476
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 21	0.000541419	0.020311956543392476
ADRENOLEUKODYSTROPHY	0.000541419	0.020311956543392476
LISSENCEPHALY, X-LINKED, 1; LISX1	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.000541419	0.020311956543392476
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000541419	0.020311956543392476
ZUNICH NEUROECTODERMAL SYNDROME	0.000541419	0.020311956543392476
WEAVER SYNDROME	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.000541419	0.020311956543392476
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000541419	0.020311956543392476
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.020311956543392476
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 103	0.000541419	0.020311956543392476
XQ25 DUPLICATION SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.000541419	0.020311956543392476
MEND SYNDROME; MEND	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 102	0.000541419	0.020311956543392476
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 101; MRX101	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.020311956543392476
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 91; MRX91	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000541419	0.020311956543392476
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.000541419	0.020311956543392476
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 88	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 90	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.020311956543392476
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.020311956543392476
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.020311956543392476
CLARK-BARAITSER SYNDROME	0.000541419	0.020311956543392476
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.000541419	0.020311956543392476
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392476
THYROCEREBRORETINAL SYNDROME	0.000541419	0.020311956543392476
THREONINEMIA	0.000541419	0.020311956543392476
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.000541419	0.020311956543392476
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.000541419	0.020311956543392476
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.000541419	0.020311956543392476
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.020311956543392476
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.000541419	0.020311956543392476
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.020311956543392476
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.000541419	0.020311956543392476
METACHROMATIC LEUKODYSTROPHY	0.000541419	0.020311956543392476
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.000541419	0.020311956543392476
OHDO SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.020311956543392476
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000541419	0.020311956543392476
MEGALENCEPHALY WITH DYSMYELINATION	0.000541419	0.020311956543392476
TAY-SACHS DISEASE; TSD	0.000541419	0.020311956543392476
MARDEN-WALKER SYNDROME	0.000541419	0.020311956543392476
MACDERMOT-WINTER SYNDROME	0.000541419	0.020311956543392476
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.020311956543392476
LANDAU-KLEFFNER SYNDROME	0.000541419	0.020311956543392476
KIFAFA SEIZURE DISORDER	0.000541419	0.020311956543392476
KEUTEL SYNDROME; KTLS	0.000541419	0.020311956543392476
KETOADIPICACIDURIA	0.000541419	0.020311956543392476
KAPUR-TORIELLO SYNDROME	0.000541419	0.020311956543392476
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.020311956543392476
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.020311956543392476
HYPERPROLINEMIA, TYPE II	0.000541419	0.020311956543392476
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.000541419	0.020311956543392476
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000541419	0.020311956543392476
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000541419	0.020311956543392476
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000541419	0.020311956543392476
GM2-GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.020311956543392476
FILIPPI SYNDROME; FLPIS	0.000541419	0.020311956543392476
SULFOCYSTEINURIA	0.000541419	0.020311956543392476
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.000541419	0.020311956543392476
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.020311956543392476
INFANTILE SIALIC ACID STORAGE DISEASE	0.000541419	0.020311956543392476
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000541419	0.020311956543392476
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.000541419	0.020311956543392476
KNOBLOCH SYNDROME 1; KNO1	0.000541419	0.020311956543392476
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.020311956543392476
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.000541419	0.020311956543392476
RAMON SYNDROME	0.000541419	0.020311956543392476
PHENYLKETONURIA	0.000541419	0.020311956543392476
PETERS-PLUS SYNDROME; PTRPLS	0.000541419	0.020311956543392476
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.000541419	0.020311956543392476
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000541419	0.020311956543392476
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.000541419	0.020311956543392476
ELEJALDE DISEASE	0.000541419	0.020311956543392476
NEURAMINIDASE DEFICIENCY	0.000541419	0.020311956543392476
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000541419	0.020311956543392476
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.000541419	0.020311956543392476
COCKAYNE SYNDROME	0.000541419	0.020311956543392476
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.000541419	0.020311956543392476
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.000541419	0.020311956543392476
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.020311956543392476
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.020311956543392476
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.000541419	0.020311956543392476
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.000541419	0.020311956543392476
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.000541419	0.020311956543392476
FRONTAL ENCEPHALOCELE	0.000541419	0.020311956543392476
COHEN SYNDROME	0.000541419	0.020311956543392476
COFFIN-LOWRY SYNDROME	0.000541419	0.020311956543392476
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.000541419	0.020311956543392476
EDINBURGH MALFORMATION SYNDROME	0.000541419	0.020311956543392476
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.020311956543392476
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392476
THANATOPHORIC DYSPLASIA TYPE 1	0.000541419	0.020311956543392476
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.000541419	0.020311956543392476
ACROMELIC FRONTONASAL DYSPLASIA	0.000541419	0.020311956543392476
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
DYSEQUILIBRIUM SYNDROME	0.000541419	0.020311956543392476
FAMILIAL DYSAUTONOMIA	0.000541419	0.020311956543392476
22Q11.2 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.000541419	0.020311956543392476
DISTAL TRISOMY 15Q	0.000541419	0.020311956543392476
CORNELIA DE LANGE SYNDROME	0.000541419	0.020311956543392476
EAST SYNDROME	0.000541419	0.020311956543392476
MOWAT-WILSON SYNDROME	0.000541419	0.020311956543392476
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.000541419	0.020311956543392476
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.020311956543392476
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.020311956543392476
DONNAI-BARROW SYNDROME	0.000541419	0.020311956543392476
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.000541419	0.020311956543392476
HENNEKAM SYNDROME	0.000541419	0.020311956543392476
HENNEKAM-BEEMER SYNDROME	0.000541419	0.020311956543392476
CYSTATHIONINURIA	0.000541419	0.020311956543392476
HARROD SYNDROME	0.000541419	0.020311956543392476
HALL-RIGGS SYNDROME	0.000541419	0.020311956543392476
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.020311956543392476
ADULT-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.020311956543392476
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.020311956543392476
GALLOWAY-MOWAT SYNDROME	0.000541419	0.020311956543392476
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.000541419	0.020311956543392476
FRYNS SYNDROME	0.000541419	0.020311956543392476
CRIGLER-NAJJAR SYNDROME	0.000541419	0.020311956543392476
FOIX-CHAVANY-MARIE SYNDROME	0.000541419	0.020311956543392476
FLYNN-AIRD SYNDROME	0.000541419	0.020311956543392476
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.000541419	0.020311956543392476
COWDEN SYNDROME	0.000541419	0.020311956543392476
ACROCARDIOFACIAL SYNDROME	0.000541419	0.020311956543392476
MOSAIC TRISOMY 14	0.000541419	0.020311956543392476
CHILDHOOD DISINTEGRATIVE DISORDER	0.000541419	0.020311956543392476
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.000541419	0.020311956543392476
COFFIN-SIRIS SYNDROME	0.000541419	0.020311956543392476
RING CHROMOSOME 22 SYNDROME	0.000541419	0.020311956543392476
RING CHROMOSOME 10 SYNDROME	0.000541419	0.020311956543392476
XQ21 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.020311956543392476
CANAVAN DISEASE	0.000541419	0.020311956543392476
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.000541419	0.020311956543392476
ISOLATED CEREBELLAR AGENESIS	0.000541419	0.020311956543392476
17Q11.2 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.000541419	0.020311956543392476
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.020311956543392476
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.000541419	0.020311956543392476
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392476
SYMMETRICAL THALAMIC CALCIFICATIONS	0.000541419	0.020311956543392476
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.020311956543392476
C SYNDROME	0.000541419	0.020311956543392476
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.000541419	0.020311956543392476
BRANCHIOSKELETOGENITAL SYNDROME	0.000541419	0.020311956543392476
BOWEN-CONRADI SYNDROME	0.000541419	0.020311956543392476
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.000541419	0.020311956543392476
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.000541419	0.020311956543392476
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.020311956543392476
PROGRESSIVE HEMIFACIAL ATROPHY	0.000541419	0.020311956543392476
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.000541419	0.020311956543392476
COFS SYNDROME	0.000541419	0.020311956543392476
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.020311956543392476
MULTIPLE CARBOXYLASE DEFICIENCY	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.000541419	0.020311956543392476
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.020311956543392476
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.020311956543392476
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.000541419	0.020311956543392476
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.000541419	0.020311956543392476
DISTAL MONOSOMY 7Q36	0.000541419	0.020311956543392476
DISTAL MONOSOMY 3P	0.000541419	0.020311956543392476
2Q24 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
1P36 DELETION SYNDROME	0.000541419	0.020311956543392476
MONOSOMY 18Q	0.000541419	0.020311956543392476
DISTAL MONOSOMY 15Q	0.000541419	0.020311956543392476
HUNTINGTON DISEASE-LIKE 3	0.000541419	0.020311956543392476
HUNTINGTON DISEASE-LIKE 1	0.000541419	0.020311956543392476
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.000541419	0.020311956543392476
KNOBLOCH SYNDROME	0.000541419	0.020311956543392476
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.000541419	0.020311956543392476
FAMILIAL BENIGN COPPER DEFICIENCY	0.000541419	0.020311956543392476
CRISPONI SYNDROME	0.000541419	0.020311956543392476
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.000541419	0.020311956543392476
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.020311956543392476
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.000541419	0.020311956543392476
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.020311956543392476
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.000541419	0.020311956543392476
BETA-MANNOSIDOSIS	0.000541419	0.020311956543392476
21Q22.11Q22.12 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.000541419	0.020311956543392476
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.000541419	0.020311956543392476
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.000541419	0.020311956543392476
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392476
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.000541419	0.020311956543392476
THANATOPHORIC DYSPLASIA	0.000541419	0.020311956543392476
TRISOMY 8P	0.000541419	0.020311956543392476
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.000541419	0.020311956543392476
KLEEFSTRA SYNDROME	0.000541419	0.020311956543392476
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
20Q13.33 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
OROFACIODIGITAL SYNDROME TYPE 6	0.000541419	0.020311956543392476
20P12.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
16Q24.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
LINEAR NEVUS SEBACEUS SYNDROME	0.000541419	0.020311956543392476
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
15Q14 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
14Q12 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
MONOSOMY 9P	0.000541419	0.020311956543392476
LINEAR VERRUCOUS NEVUS SYNDROME	0.000541419	0.020311956543392476
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.020311956543392476
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.020311956543392476
10Q22.3Q23.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.020311956543392476
XP22.13P22.2 DUPLICATION SYNDROME	0.000541419	0.020311956543392476
PORENCEPHALY	0.000541419	0.020311956543392476
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.000541419	0.020311956543392476
CRONKHITE-CANADA SYNDROME	0.000541419	0.020311956543392476
CONGENITAL RUBELLA SYNDROME	0.000541419	0.020311956543392476
MEVALONIC ACIDURIA	0.000541419	0.020311956543392476
PITT-HOPKINS SYNDROME	0.000541419	0.020311956543392476
TARP SYNDROME	0.000541419	0.020311956543392476
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.020311956543392476
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.000541419	0.020311956543392476
TYROSINEMIA TYPE 2	0.000541419	0.020311956543392476
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.000541419	0.020311956543392476
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.000541419	0.020311956543392476
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.000541419	0.020311956543392476
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020311956543392476
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.000541419	0.020311956543392476
MICROFORM HOLOPROSENCEPHALY	0.000541419	0.020311956543392476
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.020311956543392476
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.020311956543392476
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
NASU-HAKOLA DISEASE	0.000541419	0.020311956543392476
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.000541419	0.020311956543392476
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.000541419	0.020311956543392476
MOYNAHAN SYNDROME	0.000541419	0.020311956543392476
MOMO SYNDROME	0.000541419	0.020311956543392476
5Q35 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
DUBOWITZ SYNDROME	0.000541419	0.020311956543392476
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.000541419	0.020311956543392476
KBG SYNDROME	0.000541419	0.020311956543392476
DUANE RETRACTION SYNDROME	0.000541419	0.020311956543392476
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.000541419	0.020311956543392476
SANJAD-SAKATI SYNDROME	0.000541419	0.020311956543392476
KABUKI SYNDROME	0.000541419	0.020311956543392476
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.000541419	0.020311956543392476
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.000541419	0.020311956543392476
JACOBSEN SYNDROME	0.000541419	0.020311956543392476
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.000541419	0.020311956543392476
2Q23.1 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
5Q14.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.000541419	0.020311956543392476
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.000541419	0.020311956543392476
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.020311956543392476
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.000541419	0.020311956543392476
MATERNAL PHENYLKETONURIA	0.000541419	0.020311956543392476
JOUBERT SYNDROME WITH RENAL DEFECT	0.000541419	0.020311956543392476
JOUBERT SYNDROME WITH OCULAR DEFECT	0.000541419	0.020311956543392476
CONGENITAL HYDROCEPHALUS	0.000541419	0.020311956543392476
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.000541419	0.020311956543392476
HYDRANENCEPHALY	0.000541419	0.020311956543392476
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
15Q11Q13 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
4Q21 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.000541419	0.020311956543392476
19P13.12 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.000541419	0.020311956543392476
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.000541419	0.020311956543392476
CK SYNDROME	0.000541419	0.020311956543392476
8P23.1 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
8P11.2 DELETION SYNDROME	0.000541419	0.020311956543392476
6Q25 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
3Q29 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
2Q31.1 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.020311956543392476
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.020311956543392476
MICRO SYNDROME	0.000541419	0.020311956543392476
1Q41Q42 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
1Q21.1 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
1Q21.1 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
AICA-RIBOSIDURIA	0.000541419	0.020311956543392476
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.000541419	0.020311956543392476
JUVENILE HUNTINGTON DISEASE	0.000541419	0.020311956543392476
NEUROCUTANEOUS MELANOCYTOSIS	0.000541419	0.020311956543392476
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
CENTRAL BILATERAL MACROGYRIA	0.000541419	0.020311956543392476
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.020311956543392476
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.000541419	0.020311956543392476
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.000541419	0.020311956543392476
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000541419	0.020311956543392476
COFFIN-SIRIS SYNDROME 5	0.000541419	0.020311956543392476
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000541419	0.020311956543392476
HEART AND BRAIN MALFORMATION SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.000541419	0.020311956543392476
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000541419	0.020311956543392476
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.000541419	0.020311956543392476
CHROMOSOME 16P13.2 DELETION SYNDROME	0.000541419	0.020311956543392476
LUSCAN-LUMISH SYNDROME; LLS	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.000541419	0.020311956543392476
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.000541419	0.020311956543392476
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.000541419	0.020311956543392476
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.000541419	0.020311956543392476
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.000541419	0.020311956543392476
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.000541419	0.020311956543392476
DESANTO-SHINAWI SYNDROME	0.000541419	0.020311956543392476
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.000541419	0.020311956543392476
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.000541419	0.020311956543392476
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.000541419	0.020311956543392476
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.000541419	0.020311956543392476
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.000541419	0.020311956543392476
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000541419	0.020311956543392476
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.000541419	0.020311956543392476
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.000541419	0.020311956543392476
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.000541419	0.020311956543392476
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.000541419	0.020311956543392476
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.000541419	0.020311956543392476
LISSENCEPHALY 8; LIS8	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 49; IMD49	0.000541419	0.020311956543392476
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.000541419	0.020311956543392476
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.000541419	0.020311956543392476
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.000541419	0.020311956543392476
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.000541419	0.020311956543392476
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.000541419	0.020311956543392476
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.000541419	0.020311956543392476
ZTTK SYNDROME; ZTTKS	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.020311956543392476
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.000541419	0.020311956543392476
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000541419	0.020311956543392476
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.000541419	0.020311956543392476
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.000541419	0.020311956543392476
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.000541419	0.020311956543392476
WEBB-DATTANI SYNDROME; WEDAS	0.000541419	0.020311956543392476
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.000541419	0.020311956543392476
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000541419	0.020311956543392476
HELSMOORTEL-VAN DER AA SYNDROME	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.000541419	0.020311956543392476
AICARDI-GOUTIERES SYNDROME 7	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.000541419	0.020311956543392476
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.000541419	0.020311956543392476
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.000541419	0.020311956543392476
CHROMOSOME 5Q12 DELETION SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.000541419	0.020311956543392476
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.000541419	0.020311956543392476
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.000541419	0.020311956543392476
SCHAAF-YANG SYNDROME; SHFYNG	0.000541419	0.020311956543392476
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000541419	0.020311956543392476
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.000541419	0.020311956543392476
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.020311956543392476
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.000541419	0.020311956543392476
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.000541419	0.020311956543392476
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.000541419	0.020311956543392476
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000541419	0.020311956543392476
ADAMS-OLIVER SYNDROME 5; AOS5	0.000541419	0.020311956543392476
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.000541419	0.020311956543392476
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.000541419	0.020311956543392476
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.020311956543392476
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.000541419	0.020311956543392476
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.000541419	0.020311956543392476
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.000541419	0.020311956543392476
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.000541419	0.020311956543392476
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.000541419	0.020311956543392476
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000541419	0.020311956543392476
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.000541419	0.020311956543392476
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.000541419	0.020311956543392476
CATEL-MANZKE SYNDROME; CATMANS	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000541419	0.020311956543392476
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000541419	0.020311956543392476
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.000541419	0.020311956543392476
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.000541419	0.020311956543392476
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.000541419	0.020311956543392476
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.000541419	0.020311956543392476
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.000541419	0.020311956543392476
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.000541419	0.020311956543392476
COFFIN-SIRIS SYNDROME 8; CSS8	0.000541419	0.020311956543392476
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.000541419	0.020311956543392476
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.000541419	0.020311956543392476
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.000541419	0.020311956543392476
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.000541419	0.020311956543392476
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.000541419	0.020311956543392476
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.000541419	0.020311956543392476
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.000541419	0.020311956543392476
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.000541419	0.020311956543392476
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.020311956543392476
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.000541419	0.020311956543392476
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.000541419	0.020311956543392476
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.000541419	0.020311956543392476
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.020311956543392476
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.000541419	0.020311956543392476
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.000541419	0.020311956543392476
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.000541419	0.020311956543392476
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.020311956543392476
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.020311956543392476
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.000541419	0.020311956543392476
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.000541419	0.020311956543392476
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.000541419	0.020311956543392476
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.000541419	0.020311956543392476
ROMANO-WARD SYNDROME	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.020311956543392476
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.000541419	0.020311956543392476
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.020311956543392476
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.000541419	0.020311956543392476
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
2Q37 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
48,XXYY SYNDROME	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.000541419	0.020311956543392476
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000541419	0.020311956543392476
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.000541419	0.020311956543392476
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.000541419	0.020311956543392476
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.000541419	0.020311956543392476
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.000541419	0.020311956543392476
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.000541419	0.020311956543392476
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.000541419	0.020311956543392476
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.000541419	0.020311956543392476
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.000541419	0.020311956543392476
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.000541419	0.020311956543392476
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.020311956543392476
KLEEFSTRA SYNDROME 2; KLEFS2	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.000541419	0.020311956543392476
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.000541419	0.020311956543392476
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.000541419	0.020311956543392476
AL KAISSI SYNDROME; ALKAS	0.000541419	0.020311956543392476
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000541419	0.020311956543392476
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.000541419	0.020311956543392476
JOUBERT SYNDROME 30; JBTS30	0.000541419	0.020311956543392476
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.000541419	0.020311956543392476
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.000541419	0.020311956543392476
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.000541419	0.020311956543392476
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.000541419	0.020311956543392476
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.020311956543392476
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.000541419	0.020311956543392476
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.000541419	0.020311956543392476
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.000541419	0.020311956543392476
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.000541419	0.020311956543392476
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.000541419	0.020311956543392476
JABERI-ELAHI SYNDROME; JABELS	0.000541419	0.020311956543392476
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.020311956543392476
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.000541419	0.020311956543392476
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA 47; SCA47	0.000541419	0.020311956543392476
CHROMOSOME 1P35 DELETION SYNDROME	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.020311956543392476
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000541419	0.020311956543392476
